date
Note that the current default version of R is 3.6.1.
Loading required package: network
network: Classes for Relational Data
Version 1.15 created on 2019-04-01.
copyright (c) 2005, Carter T. Butts, University of California-Irvine
                    Mark S. Handcock, University of California -- Los Angeles
                    David R. Hunter, Penn State University
                    Martina Morris, University of Washington
                    Skye Bender-deMoll, University of Washington
 For citation information, type citation("network").
 Type help("network-package") to get started.


networkDynamic: version 0.10.0, created on 2019-04-04
Copyright (c) 2019, Carter T. Butts, University of California -- Irvine
                    Ayn Leslie-Cook, University of Washington
                    Pavel N. Krivitsky, University of Wollongong
                    Skye Bender-deMoll, University of Washington
                    with contributions from
                    Zack Almquist, University of California -- Irvine
                    David R. Hunter, Penn State University
                    Li Wang
                    Kirk Li, University of Washington
                    Steven M. Goodreau, University of Washington
                    Jeffrey Horner
                    Martina Morris, University of Washington
Based on "statnet" project software (statnet.org).
For license and citation information see statnet.org/attribution
or type citation("networkDynamic").

Loading required package: statnet.common

Attaching package: ‘statnet.common’

The following object is masked from ‘package:base’:

    order

sna: Tools for Social Network Analysis
Version 2.4 created on 2016-07-23.
copyright (c) 2005, Carter T. Butts, University of California-Irvine
 For citation information, type citation("sna").
 Type help(package="sna") to get started.


ergm: version 3.10.4, created on 2019-06-10
Copyright (c) 2019, Mark S. Handcock, University of California -- Los Angeles
                    David R. Hunter, Penn State University
                    Carter T. Butts, University of California -- Irvine
                    Steven M. Goodreau, University of Washington
                    Pavel N. Krivitsky, University of Wollongong
                    Martina Morris, University of Washington
                    with contributions from
                    Li Wang
                    Kirk Li, University of Washington
                    Skye Bender-deMoll, University of Washington
                    Chad Klumb
Based on "statnet" project software (statnet.org).
For license and citation information see statnet.org/attribution
or type citation("ergm").

NOTE: Versions before 3.6.1 had a bug in the implementation of the bd()
constriant which distorted the sampled distribution somewhat. In
addition, Sampson's Monks datasets had mislabeled vertices. See the
NEWS and the documentation for more details.

NOTE: Some common term arguments pertaining to vertex attribute and
level selection have changed in 3.10.0. See terms help for more
details. Use ‘options(ergm.term=list(version="3.9.4"))’ to use old
behavior.


tergm: version 3.6.1, created on 2019-06-12
Copyright (c) 2019, Pavel N. Krivitsky, University of Wollongong
                    Mark S. Handcock, University of California -- Los Angeles
                    with contributions from
                    David R. Hunter, Penn State University
                    Steven M. Goodreau, University of Washington
                    Martina Morris, University of Washington
                    Nicole Bohme Carnegie, New York University
                    Carter T. Butts, University of California -- Irvine
                    Ayn Leslie-Cook, University of Washington
                    Skye Bender-deMoll
                    Li Wang
                    Kirk Li, University of Washington
Based on "statnet" project software (statnet.org).
For license and citation information see statnet.org/attribution
or type citation("tergm").

Starting maximum pseudolikelihood estimation (MPLE):
Evaluating the predictor and response matrix.
Maximizing the pseudolikelihood.
Finished MPLE.
Starting Monte Carlo maximum likelihood estimation (MCMLE):
Iteration 1 of at most 500:
Optimizing with step length 0.32590646859481.
The log-likelihood improved by 3.921.
Iteration 2 of at most 500:
Optimizing with step length 0.381203077824842.
The log-likelihood improved by 3.992.
Iteration 3 of at most 500:
Optimizing with step length 0.96517719777582.
The log-likelihood improved by 2.984.
Iteration 4 of at most 500:
Optimizing with step length 1.
The log-likelihood improved by 0.4367.
Step length converged once. Increasing MCMC sample size.
Iteration 5 of at most 500:
Optimizing with step length 1.
The log-likelihood improved by 0.08045.
Step length converged twice. Stopping.
Finished MCMLE.
This model was fit using MCMC.  To examine model diagnostics and check
for degeneracy, use the mcmc.diagnostics() function.
 degree0  degree1  degree2  degree3  degree4  degree5  degree6  degree7 
       1       19     1247     1054      775      320      402      330 
 degree8  degree9 degree10 degree11 degree12 degree13 degree14 degree15 
     300      233      137       96       41       19       14        5 
degree16 degree17 
       3        4 
1 
disease_progression 
H-positive risk:  867 875 115 911 408 130 900 437 113 59 117 68 
H-negative risk:  875 867 900 911 437 408 130 115 117 113 68 59 
New BC onsets:  0
BC status:  5000 
BC subtype:  5000 

clinical_engagement 
diagnosis 
demography 
49 new agents 
2 
disease_progression 
H-positive risk:  875 878 114 910 406 127 899 434 115 59 116 67 
H-negative risk:  878 875 899 910 434 406 127 114 116 115 67 59 
New BC onsets:  2
BC status:  4998 2 
BC subtype:  4998 2 

clinical_engagement 
diagnosis 
demography 
54 new agents 
3 
disease_progression 
H-positive risk:  876 886 115 907 403 128 896 432 116 60 114 67 
H-negative risk:  886 876 896 907 432 403 128 115 114 116 67 60 
New BC onsets:  3
BC status:  4997 3 
BC subtype:  4997 3 

clinical_engagement 
diagnosis 
demography 
51 new agents 
4 
disease_progression 
H-positive risk:  882 887 116 912 399 128 896 426 115 59 114 66 
H-negative risk:  887 882 896 912 426 399 128 116 114 115 66 59 
New BC onsets:  5
BC status:  4995 5 
BC subtype:  4995 4 1 

clinical_engagement 
diagnosis 
demography 
63 new agents 
5 
disease_progression 
H-positive risk:  888 894 117 903 398 128 899 423 112 57 114 67 
H-negative risk:  894 888 899 903 423 398 128 117 114 112 67 57 
New BC onsets:  7
BC status:  4993 7 
BC subtype:  4993 6 1 

clinical_engagement 
diagnosis 
demography 
68 new agents 
6 
disease_progression 
H-positive risk:  893 901 118 900 395 128 896 417 114 57 115 66 
H-negative risk:  901 893 896 900 417 395 128 118 115 114 66 57 
New BC onsets:  9
BC status:  4991 9 
BC subtype:  4991 8 1 

clinical_engagement 
diagnosis 
demography 
54 new agents 
7 
disease_progression 
H-positive risk:  899 909 119 897 388 128 898 413 112 57 115 65 
H-negative risk:  909 899 898 897 413 388 128 119 115 112 65 57 
New BC onsets:  12
BC status:  4988 12 
BC subtype:  4988 11 1 

clinical_engagement 
diagnosis 
demography 
68 new agents 
8 
disease_progression 
H-positive risk:  902 915 117 897 391 126 897 412 111 56 115 61 
H-negative risk:  915 902 897 897 412 391 126 117 115 111 61 56 
New BC onsets:  12
BC status:  4988 12 
BC subtype:  4988 11 1 

clinical_engagement 
diagnosis 
demography 
62 new agents 
9 
disease_progression 
H-positive risk:  907 925 117 898 379 126 893 413 112 57 113 60 
H-negative risk:  925 907 893 898 413 379 126 117 113 112 60 57 
New BC onsets:  12
BC status:  4988 12 
BC subtype:  4988 11 1 

clinical_engagement 
diagnosis 
demography 
60 new agents 
10 
disease_progression 
H-positive risk:  911 931 119 894 371 127 900 400 116 58 112 61 
H-negative risk:  931 911 900 894 400 371 127 119 112 116 61 58 
New BC onsets:  14
BC status:  4986 14 
BC subtype:  4986 13 1 

clinical_engagement 
diagnosis 
demography 
62 new agents 
11 
disease_progression 
H-positive risk:  915 935 120 890 365 128 902 401 115 55 112 62 
H-negative risk:  935 915 902 890 401 365 128 120 112 115 62 55 
New BC onsets:  17
BC status:  4983 17 
BC subtype:  4983 14 3 

clinical_engagement 
diagnosis 
demography 
57 new agents 
12 
disease_progression 
H-positive risk:  915 932 119 892 363 132 903 401 113 55 113 62 
H-negative risk:  932 915 903 892 401 363 132 119 113 113 62 55 
New BC onsets:  16
BC status:  4984 16 
BC subtype:  4984 14 2 

clinical_engagement 
diagnosis 
demography 
62 new agents 
13 
disease_progression 
H-positive risk:  845 850 111 977 361 124 973 399 123 55 123 59 
H-negative risk:  850 845 973 977 399 361 124 111 123 123 59 55 
New BC onsets:  18
BC status:  4982 18 
BC subtype:  4982 16 2 

clinical_engagement 
diagnosis 
demography 
204 new agents 
14 
disease_progression 
H-positive risk:  872 882 116 923 391 129 922 419 113 58 115 60 
H-negative risk:  882 872 922 923 419 391 129 116 115 113 60 58 
New BC onsets:  23
BC status:  4977 23 
BC subtype:  4977 21 2 

clinical_engagement 
diagnosis 
demography 
60 new agents 
15 
disease_progression 
H-positive risk:  877 888 115 921 392 129 921 415 113 58 115 56 
H-negative risk:  888 877 921 921 415 392 129 115 115 113 56 58 
New BC onsets:  26
BC status:  4974 26 
BC subtype:  4974 24 2 

clinical_engagement 
diagnosis 
demography 
54 new agents 
16 
disease_progression 
H-positive risk:  874 901 114 914 388 130 920 418 112 58 115 56 
H-negative risk:  901 874 920 914 418 388 130 114 115 112 56 58 
New BC onsets:  27
BC status:  4973 27 
BC subtype:  4973 25 2 

clinical_engagement 
diagnosis 
demography 
70 new agents 
17 
disease_progression 
H-positive risk:  885 907 116 910 379 132 917 417 111 57 115 54 
H-negative risk:  907 885 917 910 417 379 132 116 115 111 54 57 
New BC onsets:  26
BC status:  4974 26 
BC subtype:  4974 24 2 

clinical_engagement 
diagnosis 
demography 
51 new agents 
18 
disease_progression 
H-positive risk:  884 912 116 908 375 130 915 420 113 57 116 54 
H-negative risk:  912 884 915 908 420 375 130 116 116 113 54 57 
New BC onsets:  29
BC status:  4971 29 
BC subtype:  4971 26 3 

clinical_engagement 
diagnosis 
demography 
54 new agents 
19 
disease_progression 
H-positive risk:  880 915 118 906 378 130 917 416 115 56 116 53 
H-negative risk:  915 880 917 906 416 378 130 118 116 115 53 56 
New BC onsets:  34
BC status:  4966 34 
BC subtype:  4966 30 4 

clinical_engagement 
diagnosis 
demography 
59 new agents 
20 
disease_progression 
H-positive risk:  886 914 118 905 376 131 911 422 113 58 116 50 
H-negative risk:  914 886 911 905 422 376 131 118 116 113 50 58 
New BC onsets:  36
BC status:  4964 36 
BC subtype:  4964 32 4 

clinical_engagement 
diagnosis 
demography 
64 new agents 
21 
disease_progression 
H-positive risk:  901 924 117 900 368 132 906 415 113 57 118 49 
H-negative risk:  924 901 906 900 415 368 132 117 118 113 49 57 
New BC onsets:  38
BC status:  4962 38 
BC subtype:  4962 35 3 

clinical_engagement 
diagnosis 
demography 
67 new agents 
22 
disease_progression 
H-positive risk:  913 929 115 904 368 132 898 407 112 56 117 49 
H-negative risk:  929 913 898 904 407 368 132 115 117 112 49 56 
New BC onsets:  41
BC status:  4959 41 
BC subtype:  4959 37 4 

clinical_engagement 
diagnosis 
demography 
62 new agents 
23 
disease_progression 
H-positive risk:  913 927 114 906 362 132 903 407 110 54 122 50 
H-negative risk:  927 913 903 906 407 362 132 114 122 110 50 54 
New BC onsets:  42
BC status:  4958 42 
BC subtype:  4958 37 5 

clinical_engagement 
diagnosis 
demography 
44 new agents 
24 
disease_progression 
H-positive risk:  916 931 114 912 364 133 888 405 109 54 124 50 
H-negative risk:  931 916 888 912 405 364 133 114 124 109 50 54 
New BC onsets:  42
BC status:  4958 42 
BC subtype:  4958 37 5 

clinical_engagement 
diagnosis 
demography 
45 new agents 
25 
disease_progression 
H-positive risk:  844 860 104 992 363 127 952 403 121 54 131 49 
H-negative risk:  860 844 952 992 403 363 127 104 131 121 49 54 
New BC onsets:  42
BC status:  4958 42 
BC subtype:  4958 37 5 

clinical_engagement 
diagnosis 
demography 
190 new agents 
26 
disease_progression 
H-positive risk:  870 882 106 952 386 128 909 422 115 53 127 50 
H-negative risk:  882 870 909 952 422 386 128 106 127 115 50 53 
New BC onsets:  46
BC status:  4954 46 
BC subtype:  4954 36 10 

clinical_engagement 
diagnosis 
demography 
72 new agents 
27 
disease_progression 
H-positive risk:  880 881 106 960 378 128 907 422 112 52 124 50 
H-negative risk:  881 880 907 960 422 378 128 106 124 112 50 52 
New BC onsets:  46
BC status:  4954 46 
BC subtype:  4954 35 11 

clinical_engagement 
diagnosis 
demography 
72 new agents 
28 
disease_progression 
H-positive risk:  887 887 107 960 376 129 903 415 111 50 126 49 
H-negative risk:  887 887 903 960 415 376 129 107 126 111 49 50 
New BC onsets:  45
BC status:  4955 45 
BC subtype:  4955 34 11 

clinical_engagement 
diagnosis 
demography 
59 new agents 
29 
disease_progression 
H-positive risk:  887 891 108 952 375 132 907 415 110 48 126 49 
H-negative risk:  891 887 907 952 415 375 132 108 126 110 49 48 
New BC onsets:  45
BC status:  4955 45 
BC subtype:  4955 35 10 

clinical_engagement 
diagnosis 
demography 
83 new agents 
30 
disease_progression 
H-positive risk:  894 898 109 946 374 133 901 406 111 50 126 52 
H-negative risk:  898 894 901 946 406 374 133 109 126 111 52 50 
New BC onsets:  45
BC status:  4955 45 
BC subtype:  4955 35 10 

clinical_engagement 
diagnosis 
demography 
51 new agents 
31 
disease_progression 
H-positive risk:  901 902 110 943 369 133 903 403 110 50 124 52 
H-negative risk:  902 901 903 943 403 369 133 110 124 110 52 50 
New BC onsets:  46
BC status:  4954 46 
BC subtype:  4954 35 11 

clinical_engagement 
diagnosis 
demography 
54 new agents 
32 
disease_progression 
H-positive risk:  901 910 112 941 360 134 904 405 110 50 120 53 
H-negative risk:  910 901 904 941 405 360 134 112 120 110 53 50 
New BC onsets:  50
BC status:  4950 50 
BC subtype:  4950 36 14 

clinical_engagement 
diagnosis 
demography 
52 new agents 
33 
disease_progression 
H-positive risk:  904 917 112 935 363 132 903 403 108 52 120 51 
H-negative risk:  917 904 903 935 403 363 132 112 120 108 51 52 
New BC onsets:  52
BC status:  4948 52 
BC subtype:  4948 38 14 

clinical_engagement 
diagnosis 
demography 
71 new agents 
34 
disease_progression 
H-positive risk:  903 922 113 938 357 131 901 401 110 51 122 51 
H-negative risk:  922 903 901 938 401 357 131 113 122 110 51 51 
New BC onsets:  53
BC status:  4947 53 
BC subtype:  4947 38 15 

clinical_engagement 
diagnosis 
demography 
63 new agents 
35 
disease_progression 
H-positive risk:  909 921 112 942 351 132 895 403 112 51 121 51 
H-negative risk:  921 909 895 942 403 351 132 112 121 112 51 51 
New BC onsets:  52
BC status:  4948 52 
BC subtype:  4948 37 15 

clinical_engagement 
diagnosis 
demography 
55 new agents 
36 
disease_progression 
H-positive risk:  908 922 111 943 351 133 894 402 113 52 119 52 
H-negative risk:  922 908 894 943 402 351 133 111 119 113 52 52 
New BC onsets:  54
BC status:  4946 54 
BC subtype:  4946 39 15 

clinical_engagement 
diagnosis 
demography 
68 new agents 
37 
disease_progression 
H-positive risk:  853 852 104 1007 344 127 965 395 122 53 128 50 
H-negative risk:  852 853 965 1007 395 344 127 104 128 122 50 53 
New BC onsets:  56
BC status:  4944 56 
BC subtype:  4944 41 15 

clinical_engagement 
diagnosis 
demography 
149 new agents 
38 
disease_progression 
H-positive risk:  865 860 107 986 353 132 929 413 117 57 125 56 
H-negative risk:  860 865 929 986 413 353 132 107 125 117 56 57 
New BC onsets:  58
BC status:  4942 58 
BC subtype:  4942 43 15 

clinical_engagement 
diagnosis 
demography 
75 new agents 
39 
disease_progression 
H-positive risk:  868 868 108 985 347 129 929 414 113 54 128 57 
H-negative risk:  868 868 929 985 414 347 129 108 128 113 57 54 
New BC onsets:  59
BC status:  4941 59 
BC subtype:  4941 44 15 

clinical_engagement 
diagnosis 
demography 
62 new agents 
40 
disease_progression 
H-positive risk:  866 867 110 985 348 128 932 415 110 56 128 55 
H-negative risk:  867 866 932 985 415 348 128 110 128 110 55 56 
New BC onsets:  58
BC status:  4942 58 
BC subtype:  4942 43 15 

clinical_engagement 
diagnosis 
demography 
62 new agents 
41 
disease_progression 
H-positive risk:  872 866 110 980 346 129 936 413 110 56 123 59 
H-negative risk:  866 872 936 980 413 346 129 110 123 110 59 56 
New BC onsets:  58
BC status:  4942 58 
BC subtype:  4942 43 15 

clinical_engagement 
diagnosis 
demography 
70 new agents 
42 
disease_progression 
H-positive risk:  868 868 111 970 345 128 941 421 113 53 124 58 
H-negative risk:  868 868 941 970 421 345 128 111 124 113 58 53 
New BC onsets:  60
BC status:  4940 60 
BC subtype:  4940 42 18 

clinical_engagement 
diagnosis 
demography 
55 new agents 
43 
disease_progression 
H-positive risk:  872 873 113 970 342 128 935 419 113 54 123 58 
H-negative risk:  873 872 935 970 419 342 128 113 123 113 58 54 
New BC onsets:  61
BC status:  4939 61 
BC subtype:  4939 43 18 

clinical_engagement 
diagnosis 
demography 
64 new agents 
44 
disease_progression 
H-positive risk:  871 879 112 968 339 127 932 423 116 52 124 57 
H-negative risk:  879 871 932 968 423 339 127 112 124 116 57 52 
New BC onsets:  61
BC status:  4939 61 
BC subtype:  4939 44 17 

clinical_engagement 
diagnosis 
demography 
51 new agents 
45 
disease_progression 
H-positive risk:  872 877 113 965 336 127 928 426 118 52 126 60 
H-negative risk:  877 872 928 965 426 336 127 113 126 118 60 52 
New BC onsets:  61
BC status:  4939 61 
BC subtype:  4939 44 17 

clinical_engagement 
diagnosis 
demography 
58 new agents 
46 
disease_progression 
H-positive risk:  874 884 113 965 328 127 932 425 116 52 125 59 
H-negative risk:  884 874 932 965 425 328 127 113 125 116 59 52 
New BC onsets:  61
BC status:  4939 61 
BC subtype:  4939 44 17 

clinical_engagement 
diagnosis 
demography 
66 new agents 
47 
disease_progression 
H-positive risk:  882 884 116 958 327 125 937 417 120 52 124 58 
H-negative risk:  884 882 937 958 417 327 125 116 124 120 58 52 
New BC onsets:  66
BC status:  4934 66 
BC subtype:  4934 48 18 

clinical_engagement 
diagnosis 
demography 
64 new agents 
48 
disease_progression 
H-positive risk:  883 887 117 960 329 124 937 411 116 55 124 57 
H-negative risk:  887 883 937 960 411 329 124 117 124 116 57 55 
New BC onsets:  69
BC status:  4931 69 
BC subtype:  4931 51 18 

clinical_engagement 
diagnosis 
demography 
61 new agents 
49 
disease_progression 
H-positive risk:  832 839 107 1013 325 113 994 410 124 53 133 57 
H-negative risk:  839 832 994 1013 410 325 113 107 133 124 57 53 
New BC onsets:  67
BC status:  4933 67 
BC subtype:  4933 49 18 

clinical_engagement 
diagnosis 
demography 
139 new agents 
50 
disease_progression 
H-positive risk:  851 844 109 981 342 113 988 417 122 50 127 56 
H-negative risk:  844 851 988 981 417 342 113 109 127 122 56 50 
New BC onsets:  67
BC status:  4933 67 
BC subtype:  4933 46 21 

clinical_engagement 
diagnosis 
demography 
74 new agents 
51 
disease_progression 
H-positive risk:  857 843 108 993 336 114 977 419 120 52 126 55 
H-negative risk:  843 857 977 993 419 336 114 108 126 120 55 52 
New BC onsets:  68
BC status:  4932 68 
BC subtype:  4932 47 21 

clinical_engagement 
diagnosis 
demography 
80 new agents 
52 
disease_progression 
H-positive risk:  862 848 107 995 332 116 973 411 120 53 127 56 
H-negative risk:  848 862 973 995 411 332 116 107 127 120 56 53 
New BC onsets:  70
BC status:  4930 70 
BC subtype:  4930 49 21 

clinical_engagement 
diagnosis 
demography 
74 new agents 
53 
disease_progression 
H-positive risk:  872 855 106 995 319 116 970 409 119 52 131 56 
H-negative risk:  855 872 970 995 409 319 116 106 131 119 56 52 
New BC onsets:  71
BC status:  4929 71 
BC subtype:  4929 51 20 

clinical_engagement 
diagnosis 
demography 
52 new agents 
54 
disease_progression 
H-positive risk:  876 857 106 994 318 116 966 405 121 53 132 56 
H-negative risk:  857 876 966 994 405 318 116 106 132 121 56 53 
New BC onsets:  71
BC status:  4929 71 
BC subtype:  4929 50 21 

clinical_engagement 
diagnosis 
demography 
73 new agents 
55 
disease_progression 
H-positive risk:  879 861 106 992 315 115 964 407 122 52 133 54 
H-negative risk:  861 879 964 992 407 315 115 106 133 122 54 52 
New BC onsets:  72
BC status:  4928 72 
BC subtype:  4928 52 20 

clinical_engagement 
diagnosis 
demography 
72 new agents 
56 
disease_progression 
H-positive risk:  876 869 105 992 312 115 964 400 123 52 138 54 
H-negative risk:  869 876 964 992 400 312 115 105 138 123 54 52 
New BC onsets:  72
BC status:  4928 72 
BC subtype:  4928 52 20 

clinical_engagement 
diagnosis 
demography 
66 new agents 
57 
disease_progression 
H-positive risk:  875 871 103 997 312 115 966 398 121 53 138 51 
H-negative risk:  871 875 966 997 398 312 115 103 138 121 51 53 
New BC onsets:  72
BC status:  4928 72 
BC subtype:  4928 52 20 

clinical_engagement 
diagnosis 
demography 
66 new agents 
58 
disease_progression 
H-positive risk:  880 871 104 991 313 118 966 392 123 51 138 53 
H-negative risk:  871 880 966 991 392 313 118 104 138 123 53 51 
New BC onsets:  75
BC status:  4925 75 
BC subtype:  4925 54 21 

clinical_engagement 
diagnosis 
demography 
53 new agents 
59 
disease_progression 
H-positive risk:  881 873 104 987 313 118 972 386 125 50 137 54 
H-negative risk:  873 881 972 987 386 313 118 104 137 125 54 50 
New BC onsets:  73
BC status:  4927 73 
BC subtype:  4927 52 21 

clinical_engagement 
diagnosis 
demography 
74 new agents 
60 
disease_progression 
H-positive risk:  881 881 102 982 319 118 967 380 127 50 139 54 
H-negative risk:  881 881 967 982 380 319 118 102 139 127 54 50 
New BC onsets:  74
BC status:  4926 74 
BC subtype:  4926 52 22 

clinical_engagement 
diagnosis 
demography 
75 new agents 
61 
disease_progression 
H-positive risk:  822 831 95 1020 325 113 1031 378 136 51 143 55 
H-negative risk:  831 822 1031 1020 378 325 113 95 143 136 55 51 
New BC onsets:  76
BC status:  4924 76 
BC subtype:  4924 53 23 

clinical_engagement 
diagnosis 
demography 
109 new agents 
62 
disease_progression 
H-positive risk:  824 832 100 1005 346 114 1003 398 130 53 134 61 
H-negative risk:  832 824 1003 1005 398 346 114 100 134 130 61 53 
New BC onsets:  80
BC status:  4920 80 
BC subtype:  4920 57 23 

clinical_engagement 
diagnosis 
demography 
84 new agents 
63 
disease_progression 
H-positive risk:  828 834 101 1001 351 116 988 404 129 54 129 65 
H-negative risk:  834 828 988 1001 404 351 116 101 129 129 65 54 
New BC onsets:  77
BC status:  4923 77 
BC subtype:  4923 54 23 

clinical_engagement 
diagnosis 
demography 
76 new agents 
64 
disease_progression 
H-positive risk:  835 838 103 994 354 118 993 397 126 51 124 67 
H-negative risk:  838 835 993 994 397 354 118 103 124 126 67 51 
New BC onsets:  78
BC status:  4922 78 
BC subtype:  4922 55 23 

clinical_engagement 
diagnosis 
demography 
60 new agents 
65 
disease_progression 
H-positive risk:  840 843 104 994 356 119 984 395 124 48 125 68 
H-negative risk:  843 840 984 994 395 356 119 104 125 124 68 48 
New BC onsets:  82
BC status:  4918 82 
BC subtype:  4918 56 26 

clinical_engagement 
diagnosis 
demography 
65 new agents 
66 
disease_progression 
H-positive risk:  837 846 101 998 354 119 983 391 128 46 130 67 
H-negative risk:  846 837 983 998 391 354 119 101 130 128 67 46 
New BC onsets:  82
BC status:  4918 82 
BC subtype:  4918 56 26 

clinical_engagement 
diagnosis 
demography 
67 new agents 
67 
disease_progression 
H-positive risk:  829 847 103 1004 354 117 983 391 126 48 131 67 
H-negative risk:  847 829 983 1004 391 354 117 103 131 126 67 48 
New BC onsets:  79
BC status:  4921 79 
BC subtype:  4921 54 25 

clinical_engagement 
diagnosis 
demography 
66 new agents 
68 
disease_progression 
H-positive risk:  832 856 104 1001 353 115 984 382 129 47 130 67 
H-negative risk:  856 832 984 1001 382 353 115 104 130 129 67 47 
New BC onsets:  84
BC status:  4916 84 
BC subtype:  4916 60 24 

clinical_engagement 
diagnosis 
demography 
68 new agents 
69 
disease_progression 
H-positive risk:  834 859 105 1003 346 117 983 384 126 47 127 69 
H-negative risk:  859 834 983 1003 384 346 117 105 127 126 69 47 
New BC onsets:  85
BC status:  4915 85 
BC subtype:  4915 61 24 

clinical_engagement 
diagnosis 
demography 
80 new agents 
70 
disease_progression 
H-positive risk:  842 860 104 1008 342 119 984 371 127 48 129 66 
H-negative risk:  860 842 984 1008 371 342 119 104 129 127 66 48 
New BC onsets:  84
BC status:  4916 84 
BC subtype:  4916 61 23 

clinical_engagement 
diagnosis 
demography 
66 new agents 
71 
disease_progression 
H-positive risk:  848 863 105 1003 347 115 981 369 127 47 130 65 
H-negative risk:  863 848 981 1003 369 347 115 105 130 127 65 47 
New BC onsets:  85
BC status:  4915 85 
BC subtype:  4915 61 24 

clinical_engagement 
diagnosis 
demography 
79 new agents 
72 
disease_progression 
H-positive risk:  850 865 104 1001 350 120 981 364 124 45 132 64 
H-negative risk:  865 850 981 1001 364 350 120 104 132 124 64 45 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 66 23 

clinical_engagement 
diagnosis 
demography 
62 new agents 
73 
disease_progression 
H-positive risk:  793 808 99 1060 349 116 1042 359 131 42 138 63 
H-negative risk:  808 793 1042 1060 359 349 116 99 138 131 63 42 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 67 22 

clinical_engagement 
diagnosis 
demography 
118 new agents 
74 
disease_progression 
H-positive risk:  803 810 102 1041 369 115 1016 371 130 42 134 67 
H-negative risk:  810 803 1016 1041 371 369 115 102 134 130 67 42 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 70 21 

clinical_engagement 
diagnosis 
demography 
75 new agents 
75 
disease_progression 
H-positive risk:  808 821 103 1033 371 115 1009 370 133 40 133 64 
H-negative risk:  821 808 1009 1033 370 371 115 103 133 133 64 40 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 71 21 

clinical_engagement 
diagnosis 
demography 
62 new agents 
76 
disease_progression 
H-positive risk:  803 816 101 1038 372 115 1013 369 132 42 134 65 
H-negative risk:  816 803 1013 1038 369 372 115 101 134 132 65 42 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 72 22 

clinical_engagement 
diagnosis 
demography 
63 new agents 
77 
disease_progression 
H-positive risk:  801 810 101 1050 372 112 1010 371 133 42 134 64 
H-negative risk:  810 801 1010 1050 371 372 112 101 134 133 64 42 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 71 21 

clinical_engagement 
diagnosis 
demography 
79 new agents 
78 
disease_progression 
H-positive risk:  800 819 100 1054 373 112 998 372 131 42 136 63 
H-negative risk:  819 800 998 1054 372 373 112 100 136 131 63 42 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 72 22 

clinical_engagement 
diagnosis 
demography 
75 new agents 
79 
disease_progression 
H-positive risk:  802 820 100 1057 369 112 999 372 127 43 135 64 
H-negative risk:  820 802 999 1057 372 369 112 100 135 127 64 43 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 72 21 

clinical_engagement 
diagnosis 
demography 
70 new agents 
80 
disease_progression 
H-positive risk:  797 822 101 1054 365 112 1005 373 127 45 136 63 
H-negative risk:  822 797 1005 1054 373 365 112 101 136 127 63 45 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 72 21 

clinical_engagement 
diagnosis 
demography 
71 new agents 
81 
disease_progression 
H-positive risk:  804 821 101 1056 357 112 1008 371 129 46 133 62 
H-negative risk:  821 804 1008 1056 371 357 112 101 133 129 62 46 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 75 19 

clinical_engagement 
diagnosis 
demography 
67 new agents 
82 
disease_progression 
H-positive risk:  808 831 101 1055 350 113 1001 371 128 47 132 63 
H-negative risk:  831 808 1001 1055 371 350 113 101 132 128 63 47 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 73 20 

clinical_engagement 
diagnosis 
demography 
82 new agents 
83 
disease_progression 
H-positive risk:  809 835 100 1055 347 116 1003 369 123 48 134 61 
H-negative risk:  835 809 1003 1055 369 347 116 100 134 123 61 48 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 75 21 

clinical_engagement 
diagnosis 
demography 
66 new agents 
84 
disease_progression 
H-positive risk:  823 831 99 1049 345 115 1003 367 123 47 135 63 
H-negative risk:  831 823 1003 1049 367 345 115 99 135 123 63 47 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 71 20 

clinical_engagement 
diagnosis 
demography 
76 new agents 
85 
disease_progression 
H-positive risk:  785 771 90 1112 341 107 1044 364 130 50 142 64 
H-negative risk:  771 785 1044 1112 364 341 107 90 142 130 64 50 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 71 21 

clinical_engagement 
diagnosis 
demography 
108 new agents 
86 
disease_progression 
H-positive risk:  788 774 87 1087 356 106 1043 369 127 54 145 64 
H-negative risk:  774 788 1043 1087 369 356 106 87 145 127 64 54 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 75 22 

clinical_engagement 
diagnosis 
demography 
70 new agents 
87 
disease_progression 
H-positive risk:  791 773 86 1093 349 106 1041 367 130 54 148 62 
H-negative risk:  773 791 1041 1093 367 349 106 86 148 130 62 54 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 78 22 

clinical_engagement 
diagnosis 
demography 
60 new agents 
88 
disease_progression 
H-positive risk:  795 786 87 1093 347 104 1030 366 131 55 147 59 
H-negative risk:  786 795 1030 1093 366 347 104 87 147 131 59 55 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 80 22 

clinical_engagement 
diagnosis 
demography 
80 new agents 
89 
disease_progression 
H-positive risk:  794 787 85 1101 346 106 1026 365 130 54 148 58 
H-negative risk:  787 794 1026 1101 365 346 106 85 148 130 58 54 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 82 22 

clinical_engagement 
diagnosis 
demography 
62 new agents 
90 
disease_progression 
H-positive risk:  796 790 85 1102 341 107 1022 365 131 54 147 60 
H-negative risk:  790 796 1022 1102 365 341 107 85 147 131 60 54 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 79 24 

clinical_engagement 
diagnosis 
demography 
72 new agents 
91 
disease_progression 
H-positive risk:  793 791 87 1093 345 108 1034 360 130 52 146 61 
H-negative risk:  791 793 1034 1093 360 345 108 87 146 130 61 52 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 78 24 

clinical_engagement 
diagnosis 
demography 
65 new agents 
92 
disease_progression 
H-positive risk:  794 787 86 1095 352 108 1034 352 130 53 147 62 
H-negative risk:  787 794 1034 1095 352 352 108 86 147 130 62 53 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 79 22 

clinical_engagement 
diagnosis 
demography 
78 new agents 
93 
disease_progression 
H-positive risk:  790 794 88 1087 354 106 1035 353 134 50 143 66 
H-negative risk:  794 790 1035 1087 353 354 106 88 143 134 66 50 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 80 22 

clinical_engagement 
diagnosis 
demography 
67 new agents 
94 
disease_progression 
H-positive risk:  791 793 91 1101 356 104 1030 346 133 47 141 67 
H-negative risk:  793 791 1030 1101 346 356 104 91 141 133 67 47 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 82 22 

clinical_engagement 
diagnosis 
demography 
61 new agents 
95 
disease_progression 
H-positive risk:  797 797 92 1103 348 104 1026 348 134 45 139 67 
H-negative risk:  797 797 1026 1103 348 348 104 92 139 134 67 45 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 81 22 

clinical_engagement 
diagnosis 
demography 
60 new agents 
96 
disease_progression 
H-positive risk:  802 795 91 1095 348 105 1028 352 133 47 139 65 
H-negative risk:  795 802 1028 1095 352 348 105 91 139 133 65 47 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 83 22 

clinical_engagement 
diagnosis 
demography 
65 new agents 
97 
disease_progression 
H-positive risk:  754 776 86 1124 341 95 1067 355 144 46 144 68 
H-negative risk:  776 754 1067 1124 355 341 95 86 144 144 68 46 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 83 21 

clinical_engagement 
diagnosis 
demography 
116 new agents 
98 
disease_progression 
H-positive risk:  751 769 90 1114 349 95 1057 365 143 53 140 74 
H-negative risk:  769 751 1057 1114 365 349 95 90 140 143 74 53 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 84 19 

clinical_engagement 
diagnosis 
demography 
78 new agents 
99 
disease_progression 
H-positive risk:  743 773 89 1112 348 95 1063 368 146 50 138 75 
H-negative risk:  773 743 1063 1112 368 348 95 89 138 146 75 50 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 84 19 

clinical_engagement 
diagnosis 
demography 
79 new agents 
100 
disease_progression 
H-positive risk:  750 776 89 1125 339 97 1057 362 144 47 140 74 
H-negative risk:  776 750 1057 1125 362 339 97 89 140 144 74 47 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 87 18 

clinical_engagement 
diagnosis 
demography 
64 new agents 
101 
disease_progression 
H-positive risk:  753 771 89 1124 340 98 1060 364 144 45 140 72 
H-negative risk:  771 753 1060 1124 364 340 98 89 140 144 72 45 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 86 18 

clinical_engagement 
diagnosis 
demography 
80 new agents 
102 
disease_progression 
H-positive risk:  759 783 89 1120 340 100 1045 364 143 45 142 70 
H-negative risk:  783 759 1045 1120 364 340 100 89 142 143 70 45 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 86 18 

clinical_engagement 
diagnosis 
demography 
76 new agents 
103 
disease_progression 
H-positive risk:  762 784 88 1129 338 97 1038 364 144 44 143 69 
H-negative risk:  784 762 1038 1129 364 338 97 88 143 144 69 44 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 87 17 

clinical_engagement 
diagnosis 
demography 
80 new agents 
104 
disease_progression 
H-positive risk:  761 787 91 1127 333 98 1039 364 144 42 144 70 
H-negative risk:  787 761 1039 1127 364 333 98 91 144 144 70 42 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 87 16 

clinical_engagement 
diagnosis 
demography 
72 new agents 
105 
disease_progression 
H-positive risk:  761 783 91 1142 330 99 1030 358 145 43 148 70 
H-negative risk:  783 761 1030 1142 358 330 99 91 148 145 70 43 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 87 16 

clinical_engagement 
diagnosis 
demography 
59 new agents 
106 
disease_progression 
H-positive risk:  755 781 90 1146 327 99 1032 362 146 45 151 66 
H-negative risk:  781 755 1032 1146 362 327 99 90 151 146 66 45 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 87 16 

clinical_engagement 
diagnosis 
demography 
68 new agents 
107 
disease_progression 
H-positive risk:  754 774 89 1142 327 101 1040 363 147 45 151 67 
H-negative risk:  774 754 1040 1142 363 327 101 89 151 147 67 45 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 87 16 

clinical_engagement 
diagnosis 
demography 
57 new agents 
108 
disease_progression 
H-positive risk:  757 770 89 1151 324 99 1043 363 145 44 149 66 
H-negative risk:  770 757 1043 1151 363 324 99 89 149 145 66 44 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 85 14 

clinical_engagement 
diagnosis 
demography 
66 new agents 
109 
disease_progression 
H-positive risk:  713 721 86 1199 317 95 1093 364 153 43 152 64 
H-negative risk:  721 713 1093 1199 364 317 95 86 152 153 64 43 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 85 14 

clinical_engagement 
diagnosis 
demography 
90 new agents 
110 
disease_progression 
H-positive risk:  707 709 85 1182 340 96 1084 381 157 40 151 68 
H-negative risk:  709 707 1084 1182 381 340 96 85 151 157 68 40 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 86 14 

clinical_engagement 
diagnosis 
demography 
78 new agents 
111 
disease_progression 
H-positive risk:  715 706 85 1175 346 96 1077 386 155 42 150 67 
H-negative risk:  706 715 1077 1175 386 346 96 85 150 155 67 42 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 84 13 

clinical_engagement 
diagnosis 
demography 
65 new agents 
112 
disease_progression 
H-positive risk:  722 699 85 1174 351 96 1077 382 156 41 151 66 
H-negative risk:  699 722 1077 1174 382 351 96 85 151 156 66 41 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 84 13 

clinical_engagement 
diagnosis 
demography 
69 new agents 
113 
disease_progression 
H-positive risk:  723 705 85 1176 351 96 1078 379 155 40 147 65 
H-negative risk:  705 723 1078 1176 379 351 96 85 147 155 65 40 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 85 13 

clinical_engagement 
diagnosis 
demography 
69 new agents 
114 
disease_progression 
H-positive risk:  724 695 83 1173 356 96 1082 389 156 38 146 62 
H-negative risk:  695 724 1082 1173 389 356 96 83 146 156 62 38 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 85 14 

clinical_engagement 
diagnosis 
demography 
52 new agents 
115 
disease_progression 
H-positive risk:  721 696 84 1172 354 96 1091 383 157 38 146 62 
H-negative risk:  696 721 1091 1172 383 354 96 84 146 157 62 38 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 87 14 

clinical_engagement 
diagnosis 
demography 
75 new agents 
116 
disease_progression 
H-positive risk:  727 690 81 1177 352 96 1096 379 156 39 145 62 
H-negative risk:  690 727 1096 1177 379 352 96 81 145 156 62 39 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 88 14 

clinical_engagement 
diagnosis 
demography 
76 new agents 
117 
disease_progression 
H-positive risk:  730 693 81 1184 344 94 1086 385 156 39 148 60 
H-negative risk:  693 730 1086 1184 385 344 94 81 148 156 60 39 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 87 15 

clinical_engagement 
diagnosis 
demography 
56 new agents 
118 
disease_progression 
H-positive risk:  724 693 80 1180 345 93 1095 383 158 39 149 61 
H-negative risk:  693 724 1095 1180 383 345 93 80 149 158 61 39 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 88 15 

clinical_engagement 
diagnosis 
demography 
73 new agents 
119 
disease_progression 
H-positive risk:  726 695 78 1176 352 94 1092 385 153 40 148 61 
H-negative risk:  695 726 1092 1176 385 352 94 78 148 153 61 40 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 89 14 

clinical_engagement 
diagnosis 
demography 
51 new agents 
120 
disease_progression 
H-positive risk:  720 688 78 1173 359 91 1094 387 156 44 147 63 
H-negative risk:  688 720 1094 1173 387 359 91 78 147 156 63 44 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 90 14 

clinical_engagement 
diagnosis 
demography 
79 new agents 
121 
disease_progression 
H-positive risk:  687 668 73 1189 354 83 1128 390 165 46 157 60 
H-negative risk:  668 687 1128 1189 390 354 83 73 157 165 60 46 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 89 14 

clinical_engagement 
diagnosis 
demography 
105 new agents 
122 
disease_progression 
H-positive risk:  687 673 73 1178 362 82 1124 402 164 44 152 59 
H-negative risk:  673 687 1124 1178 402 362 82 73 152 164 59 44 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 88 15 

clinical_engagement 
diagnosis 
demography 
86 new agents 
123 
disease_progression 
H-positive risk:  685 673 78 1173 367 80 1134 397 161 44 149 59 
H-negative risk:  673 685 1134 1173 397 367 80 78 149 161 59 44 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 88 15 

clinical_engagement 
diagnosis 
demography 
71 new agents 
124 
disease_progression 
H-positive risk:  690 673 78 1165 366 80 1136 398 158 45 150 61 
H-negative risk:  673 690 1136 1165 398 366 80 78 150 158 61 45 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 90 15 

clinical_engagement 
diagnosis 
demography 
54 new agents 
125 
disease_progression 
H-positive risk:  682 671 78 1168 365 80 1139 403 156 45 152 61 
H-negative risk:  671 682 1139 1168 403 365 80 78 152 156 61 45 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 91 16 

clinical_engagement 
diagnosis 
demography 
74 new agents 
126 
disease_progression 
H-positive risk:  679 661 77 1177 366 80 1141 404 159 45 154 57 
H-negative risk:  661 679 1141 1177 404 366 80 77 154 159 57 45 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 93 17 

clinical_engagement 
diagnosis 
demography 
74 new agents 
127 
disease_progression 
H-positive risk:  683 662 79 1182 356 82 1147 401 158 44 154 52 
H-negative risk:  662 683 1147 1182 401 356 82 79 154 158 52 44 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 92 16 

clinical_engagement 
diagnosis 
demography 
73 new agents 
128 
disease_progression 
H-positive risk:  686 663 80 1181 357 81 1146 400 159 44 153 50 
H-negative risk:  663 686 1146 1181 400 357 81 80 153 159 50 44 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 95 16 

clinical_engagement 
diagnosis 
demography 
61 new agents 
129 
disease_progression 
H-positive risk:  679 653 81 1189 357 81 1157 397 160 44 151 51 
H-negative risk:  653 679 1157 1189 397 357 81 81 151 160 51 44 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 93 16 

clinical_engagement 
diagnosis 
demography 
78 new agents 
130 
disease_progression 
H-positive risk:  680 652 81 1197 362 80 1159 383 158 45 152 51 
H-negative risk:  652 680 1159 1197 383 362 80 81 152 158 51 45 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 93 16 

clinical_engagement 
diagnosis 
demography 
70 new agents 
131 
disease_progression 
H-positive risk:  688 658 84 1189 354 79 1168 379 155 44 151 51 
H-negative risk:  658 688 1168 1189 379 354 79 84 151 155 51 44 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 96 16 

clinical_engagement 
diagnosis 
demography 
69 new agents 
132 
disease_progression 
H-positive risk:  690 661 86 1193 351 80 1169 372 154 43 150 51 
H-negative risk:  661 690 1169 1193 372 351 80 86 150 154 51 43 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 94 16 

clinical_engagement 
diagnosis 
demography 
77 new agents 
133 
disease_progression 
H-positive risk:  684 661 87 1187 355 79 1167 378 156 42 151 53 
H-negative risk:  661 684 1167 1187 378 355 79 87 151 156 53 42 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 94 16 

clinical_engagement 
diagnosis 
demography 
80 new agents 
134 
disease_progression 
H-positive risk:  681 663 84 1163 366 75 1172 392 157 44 147 56 
H-negative risk:  663 681 1172 1163 392 366 75 84 147 157 56 44 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 94 15 

clinical_engagement 
diagnosis 
demography 
63 new agents 
135 
disease_progression 
H-positive risk:  672 663 86 1171 367 77 1171 395 153 46 145 54 
H-negative risk:  663 672 1171 1171 395 367 77 86 145 153 54 46 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 95 14 

clinical_engagement 
diagnosis 
demography 
61 new agents 
136 
disease_progression 
H-positive risk:  669 662 88 1170 364 77 1174 396 153 47 146 54 
H-negative risk:  662 669 1174 1170 396 364 77 88 146 153 54 47 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 92 15 

clinical_engagement 
diagnosis 
demography 
77 new agents 
137 
disease_progression 
H-positive risk:  670 666 92 1163 367 77 1177 391 155 43 145 54 
H-negative risk:  666 670 1177 1163 391 367 77 92 145 155 54 43 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 95 14 

clinical_engagement 
diagnosis 
demography 
78 new agents 
138 
disease_progression 
H-positive risk:  678 670 94 1171 365 78 1163 388 155 44 140 54 
H-negative risk:  670 678 1163 1171 388 365 78 94 140 155 54 44 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 92 14 

clinical_engagement 
diagnosis 
demography 
60 new agents 
139 
disease_progression 
H-positive risk:  668 674 96 1177 362 78 1162 388 154 45 142 54 
H-negative risk:  674 668 1162 1177 388 362 78 96 142 154 54 45 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 90 16 

clinical_engagement 
diagnosis 
demography 
80 new agents 
140 
disease_progression 
H-positive risk:  666 675 95 1179 359 76 1159 390 154 47 146 54 
H-negative risk:  675 666 1159 1179 390 359 76 95 146 154 54 47 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 88 16 

clinical_engagement 
diagnosis 
demography 
67 new agents 
141 
disease_progression 
H-positive risk:  670 673 95 1181 360 74 1162 385 153 45 148 54 
H-negative risk:  673 670 1162 1181 385 360 74 95 148 153 54 45 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 86 17 

clinical_engagement 
diagnosis 
demography 
77 new agents 
142 
disease_progression 
H-positive risk:  669 673 97 1185 353 76 1160 386 157 43 146 55 
H-negative risk:  673 669 1160 1185 386 353 76 97 146 157 55 43 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 84 17 

clinical_engagement 
diagnosis 
demography 
77 new agents 
143 
disease_progression 
H-positive risk:  671 682 98 1176 350 77 1158 385 160 43 145 55 
H-negative risk:  682 671 1158 1176 385 350 77 98 145 160 55 43 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 85 17 

clinical_engagement 
diagnosis 
demography 
76 new agents 
144 
disease_progression 
H-positive risk:  675 678 97 1184 351 78 1155 383 158 44 144 53 
H-negative risk:  678 675 1155 1184 383 351 78 97 144 158 53 44 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 84 18 

clinical_engagement 
diagnosis 
demography 
54 new agents 
145 
disease_progression 
H-positive risk:  672 678 98 1182 358 78 1154 382 159 43 144 52 
H-negative risk:  678 672 1154 1182 382 358 78 98 144 159 52 43 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 83 18 

clinical_engagement 
diagnosis 
demography 
101 new agents 
146 
disease_progression 
H-positive risk:  677 670 100 1168 372 78 1151 390 160 40 141 53 
H-negative risk:  670 677 1151 1168 390 372 78 100 141 160 53 40 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 85 18 

clinical_engagement 
diagnosis 
demography 
84 new agents 
147 
disease_progression 
H-positive risk:  681 670 99 1163 380 80 1142 393 160 40 140 52 
H-negative risk:  670 681 1142 1163 393 380 80 99 140 160 52 40 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 90 17 

clinical_engagement 
diagnosis 
demography 
61 new agents 
148 
disease_progression 
H-positive risk:  674 666 101 1164 383 79 1145 396 161 41 138 52 
H-negative risk:  666 674 1145 1164 396 383 79 101 138 161 52 41 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 90 17 

clinical_engagement 
diagnosis 
demography 
56 new agents 
149 
disease_progression 
H-positive risk:  680 672 101 1166 381 77 1136 397 160 43 136 51 
H-negative risk:  672 680 1136 1166 397 381 77 101 136 160 51 43 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 93 18 

clinical_engagement 
diagnosis 
demography 
72 new agents 
150 
disease_progression 
H-positive risk:  680 674 102 1161 384 77 1136 399 159 43 134 51 
H-negative risk:  674 680 1136 1161 399 384 77 102 134 159 51 43 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 93 19 

clinical_engagement 
diagnosis 
demography 
78 new agents 
151 
disease_progression 
H-positive risk:  683 669 105 1167 385 76 1141 393 156 39 135 51 
H-negative risk:  669 683 1141 1167 393 385 76 105 135 156 51 39 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 93 19 

clinical_engagement 
diagnosis 
demography 
68 new agents 
152 
disease_progression 
H-positive risk:  679 674 106 1161 387 76 1139 394 158 39 133 54 
H-negative risk:  674 679 1139 1161 394 387 76 106 133 158 54 39 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 92 17 

clinical_engagement 
diagnosis 
demography 
86 new agents 
153 
disease_progression 
H-positive risk:  692 670 108 1166 380 77 1132 400 159 37 131 48 
H-negative risk:  670 692 1132 1166 400 380 77 108 131 159 48 37 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 92 17 

clinical_engagement 
diagnosis 
demography 
67 new agents 
154 
disease_progression 
H-positive risk:  702 668 109 1150 387 79 1124 403 162 37 129 50 
H-negative risk:  668 702 1124 1150 403 387 79 109 129 162 50 37 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 89 17 

clinical_engagement 
diagnosis 
demography 
74 new agents 
155 
disease_progression 
H-positive risk:  698 666 109 1153 386 80 1120 408 165 36 128 51 
H-negative risk:  666 698 1120 1153 408 386 80 109 128 165 51 36 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 89 18 

clinical_engagement 
diagnosis 
demography 
78 new agents 
156 
disease_progression 
H-positive risk:  701 674 104 1154 385 82 1119 402 165 35 127 52 
H-negative risk:  674 701 1119 1154 402 385 82 104 127 165 52 35 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 89 19 

clinical_engagement 
diagnosis 
demography 
83 new agents 
157 
disease_progression 
H-positive risk:  701 678 104 1157 382 82 1122 395 162 36 128 53 
H-negative risk:  678 701 1122 1157 395 382 82 104 128 162 53 36 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 91 19 

clinical_engagement 
diagnosis 
demography 
83 new agents 
158 
disease_progression 
H-positive risk:  695 678 102 1164 380 83 1113 406 163 39 127 50 
H-negative risk:  678 695 1113 1164 406 380 83 102 127 163 50 39 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 93 19 

clinical_engagement 
diagnosis 
demography 
87 new agents 
159 
disease_progression 
H-positive risk:  693 678 98 1163 391 81 1107 405 163 39 132 50 
H-negative risk:  678 693 1107 1163 405 391 81 98 132 163 50 39 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 95 17 

clinical_engagement 
diagnosis 
demography 
68 new agents 
160 
disease_progression 
H-positive risk:  685 683 99 1146 395 79 1114 414 165 39 134 47 
H-negative risk:  683 685 1114 1146 414 395 79 99 134 165 47 39 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 96 17 

clinical_engagement 
diagnosis 
demography 
63 new agents 
161 
disease_progression 
H-positive risk:  687 679 99 1152 392 78 1115 417 160 39 134 48 
H-negative risk:  679 687 1115 1152 417 392 78 99 134 160 48 39 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 95 17 

clinical_engagement 
diagnosis 
demography 
98 new agents 
162 
disease_progression 
H-positive risk:  692 681 99 1146 393 79 1110 419 161 42 133 45 
H-negative risk:  681 692 1110 1146 419 393 79 99 133 161 45 42 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 91 15 

clinical_engagement 
diagnosis 
demography 
77 new agents 
163 
disease_progression 
H-positive risk:  695 684 99 1146 388 80 1107 421 160 41 132 47 
H-negative risk:  684 695 1107 1146 421 388 80 99 132 160 47 41 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 89 17 

clinical_engagement 
diagnosis 
demography 
75 new agents 
164 
disease_progression 
H-positive risk:  691 676 100 1155 386 81 1115 416 159 43 128 50 
H-negative risk:  676 691 1115 1155 416 386 81 100 128 159 50 43 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 86 21 

clinical_engagement 
diagnosis 
demography 
67 new agents 
165 
disease_progression 
H-positive risk:  688 681 98 1155 390 80 1119 413 156 43 127 50 
H-negative risk:  681 688 1119 1155 413 390 80 98 127 156 50 43 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 86 21 

clinical_engagement 
diagnosis 
demography 
58 new agents 
166 
disease_progression 
H-positive risk:  689 684 96 1157 392 83 1116 413 152 42 126 50 
H-negative risk:  684 689 1116 1157 413 392 83 96 126 152 50 42 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 86 21 

clinical_engagement 
diagnosis 
demography 
89 new agents 
167 
disease_progression 
H-positive risk:  685 681 94 1159 394 86 1122 403 152 44 132 48 
H-negative risk:  681 685 1122 1159 403 394 86 94 132 152 48 44 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 81 22 

clinical_engagement 
diagnosis 
demography 
86 new agents 
168 
disease_progression 
H-positive risk:  685 681 96 1155 392 88 1124 403 150 44 130 52 
H-negative risk:  681 685 1124 1155 403 392 88 96 130 150 52 44 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 81 22 

clinical_engagement 
diagnosis 
demography 
65 new agents 
169 
disease_progression 
H-positive risk:  682 676 95 1171 380 90 1120 412 149 45 131 49 
H-negative risk:  676 682 1120 1171 412 380 90 95 131 149 49 45 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 81 21 

clinical_engagement 
diagnosis 
demography 
86 new agents 
170 
disease_progression 
H-positive risk:  679 672 97 1173 387 90 1119 410 149 47 126 51 
H-negative risk:  672 679 1119 1173 410 387 90 97 126 149 51 47 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 79 20 

clinical_engagement 
diagnosis 
demography 
67 new agents 
171 
disease_progression 
H-positive risk:  684 672 95 1176 395 91 1099 415 147 46 128 52 
H-negative risk:  672 684 1099 1176 415 395 91 95 128 147 52 46 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 78 20 

clinical_engagement 
diagnosis 
demography 
72 new agents 
172 
disease_progression 
H-positive risk:  689 670 96 1172 388 91 1102 415 151 46 128 52 
H-negative risk:  670 689 1102 1172 415 388 91 96 128 151 52 46 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 79 21 

clinical_engagement 
diagnosis 
demography 
77 new agents 
173 
disease_progression 
H-positive risk:  685 669 96 1184 390 92 1097 411 147 49 128 52 
H-negative risk:  669 685 1097 1184 411 390 92 96 128 147 52 49 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 80 21 

clinical_engagement 
diagnosis 
demography 
70 new agents 
174 
disease_progression 
H-positive risk:  681 671 95 1177 390 92 1105 409 150 51 129 50 
H-negative risk:  671 681 1105 1177 409 390 92 95 129 150 50 51 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 81 21 

clinical_engagement 
diagnosis 
demography 
77 new agents 
175 
disease_progression 
H-positive risk:  680 672 95 1175 389 93 1108 406 150 52 131 49 
H-negative risk:  672 680 1108 1175 406 389 93 95 131 150 49 52 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 81 21 

clinical_engagement 
diagnosis 
demography 
81 new agents 
176 
disease_progression 
H-positive risk:  684 664 95 1188 386 96 1108 400 147 54 133 45 
H-negative risk:  664 684 1108 1188 400 386 96 95 133 147 45 54 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 80 21 

clinical_engagement 
diagnosis 
demography 
76 new agents 
177 
disease_progression 
H-positive risk:  686 658 98 1190 387 97 1112 396 143 55 133 45 
H-negative risk:  658 686 1112 1190 396 387 97 98 133 143 45 55 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 81 21 

clinical_engagement 
diagnosis 
demography 
63 new agents 
178 
disease_progression 
H-positive risk:  680 666 98 1181 391 97 1118 393 140 57 132 47 
H-negative risk:  666 680 1118 1181 393 391 97 98 132 140 47 57 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 83 20 

clinical_engagement 
diagnosis 
demography 
69 new agents 
179 
disease_progression 
H-positive risk:  678 670 97 1185 384 97 1124 387 139 60 132 47 
H-negative risk:  670 678 1124 1185 387 384 97 97 132 139 47 60 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 83 20 

clinical_engagement 
diagnosis 
demography 
70 new agents 
180 
disease_progression 
H-positive risk:  690 674 97 1180 381 96 1118 392 134 62 129 47 
H-negative risk:  674 690 1118 1180 392 381 96 97 129 134 47 62 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 84 21 

clinical_engagement 
diagnosis 
demography 
73 new agents 
181 
disease_progression 
H-positive risk:  686 670 97 1179 374 96 1128 395 138 59 132 46 
H-negative risk:  670 686 1128 1179 395 374 96 97 132 138 46 59 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 83 21 

clinical_engagement 
diagnosis 
demography 
95 new agents 
182 
disease_progression 
H-positive risk:  678 672 98 1183 376 99 1125 396 136 61 131 45 
H-negative risk:  672 678 1125 1183 396 376 99 98 131 136 45 61 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 82 21 

clinical_engagement 
diagnosis 
demography 
63 new agents 
183 
disease_progression 
H-positive risk:  681 673 94 1178 381 97 1119 403 137 62 130 45 
H-negative risk:  673 681 1119 1178 403 381 97 94 130 137 45 62 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 84 21 

clinical_engagement 
diagnosis 
demography 
83 new agents 
184 
disease_progression 
H-positive risk:  676 669 94 1179 378 96 1121 414 141 57 130 45 
H-negative risk:  669 676 1121 1179 414 378 96 94 130 141 45 57 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 82 21 

clinical_engagement 
diagnosis 
demography 
91 new agents 
185 
disease_progression 
H-positive risk:  675 669 96 1187 368 96 1125 411 142 59 132 40 
H-negative risk:  669 675 1125 1187 411 368 96 96 132 142 40 59 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 80 21 

clinical_engagement 
diagnosis 
demography 
86 new agents 
186 
disease_progression 
H-positive risk:  675 677 96 1189 359 97 1122 412 140 58 134 41 
H-negative risk:  677 675 1122 1189 412 359 97 96 134 140 41 58 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 78 22 

clinical_engagement 
diagnosis 
demography 
72 new agents 
187 
disease_progression 
H-positive risk:  675 678 95 1190 361 96 1126 409 140 57 136 37 
H-negative risk:  678 675 1126 1190 409 361 96 95 136 140 37 57 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 76 24 

clinical_engagement 
diagnosis 
demography 
77 new agents 
188 
disease_progression 
H-positive risk:  676 685 95 1173 365 99 1122 412 143 57 137 36 
H-negative risk:  685 676 1122 1173 412 365 99 95 137 143 36 57 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 76 24 

clinical_engagement 
diagnosis 
demography 
69 new agents 
189 
disease_progression 
H-positive risk:  676 687 92 1166 372 98 1116 412 145 60 136 40 
H-negative risk:  687 676 1116 1166 412 372 98 92 136 145 40 60 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 76 24 

clinical_engagement 
diagnosis 
demography 
60 new agents 
190 
disease_progression 
H-positive risk:  674 684 91 1160 379 98 1113 416 147 60 138 40 
H-negative risk:  684 674 1113 1160 416 379 98 91 138 147 40 60 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 77 23 

clinical_engagement 
diagnosis 
demography 
72 new agents 
191 
disease_progression 
H-positive risk:  670 679 89 1165 382 98 1115 419 146 61 136 40 
H-negative risk:  679 670 1115 1165 419 382 98 89 136 146 40 61 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 77 22 

clinical_engagement 
diagnosis 
demography 
76 new agents 
192 
disease_progression 
H-positive risk:  671 675 89 1169 384 98 1119 414 143 62 136 40 
H-negative risk:  675 671 1119 1169 414 384 98 89 136 143 40 62 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 77 23 

clinical_engagement 
diagnosis 
demography 
73 new agents 
193 
disease_progression 
H-positive risk:  671 673 89 1173 380 101 1123 415 144 57 134 40 
H-negative risk:  673 671 1123 1173 415 380 101 89 134 144 40 57 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 80 22 

clinical_engagement 
diagnosis 
demography 
78 new agents 
194 
disease_progression 
H-positive risk:  671 667 90 1169 390 99 1115 420 144 60 129 46 
H-negative risk:  667 671 1115 1169 420 390 99 90 129 144 46 60 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 83 22 

clinical_engagement 
diagnosis 
demography 
82 new agents 
195 
disease_progression 
H-positive risk:  672 660 91 1179 385 99 1110 424 142 61 130 47 
H-negative risk:  660 672 1110 1179 424 385 99 91 130 142 47 61 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 83 23 

clinical_engagement 
diagnosis 
demography 
88 new agents 
196 
disease_progression 
H-positive risk:  674 661 92 1170 396 102 1102 421 140 64 130 48 
H-negative risk:  661 674 1102 1170 421 396 102 92 130 140 48 64 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 85 23 

clinical_engagement 
diagnosis 
demography 
67 new agents 
197 
disease_progression 
H-positive risk:  677 670 91 1174 396 98 1089 425 140 63 130 47 
H-negative risk:  670 677 1089 1174 425 396 98 91 130 140 47 63 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 85 23 

clinical_engagement 
diagnosis 
demography 
92 new agents 
198 
disease_progression 
H-positive risk:  683 672 95 1171 384 100 1092 427 140 63 126 47 
H-negative risk:  672 683 1092 1171 427 384 100 95 126 140 47 63 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 80 24 

clinical_engagement 
diagnosis 
demography 
76 new agents 
199 
disease_progression 
H-positive risk:  685 665 99 1178 392 97 1088 421 139 65 120 51 
H-negative risk:  665 685 1088 1178 421 392 97 99 120 139 51 65 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 82 24 

clinical_engagement 
diagnosis 
demography 
84 new agents 
200 
disease_progression 
H-positive risk:  697 667 100 1179 388 97 1081 418 139 64 121 49 
H-negative risk:  667 697 1081 1179 418 388 97 100 121 139 49 64 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 83 23 

clinical_engagement 
diagnosis 
demography 
89 new agents 
201 
disease_progression 
H-positive risk:  687 679 106 1171 390 98 1083 420 141 61 116 48 
H-negative risk:  679 687 1083 1171 420 390 98 106 116 141 48 61 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 83 24 

clinical_engagement 
diagnosis 
demography 
74 new agents 
202 
disease_progression 
H-positive risk:  692 665 107 1180 393 97 1079 421 140 62 116 48 
H-negative risk:  665 692 1079 1180 421 393 97 107 116 140 48 62 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 81 24 

clinical_engagement 
diagnosis 
demography 
72 new agents 
203 
disease_progression 
H-positive risk:  694 668 107 1186 384 94 1067 426 145 63 116 50 
H-negative risk:  668 694 1067 1186 426 384 94 107 116 145 50 63 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 77 24 

clinical_engagement 
diagnosis 
demography 
79 new agents 
204 
disease_progression 
H-positive risk:  691 675 111 1176 388 97 1060 425 143 64 118 52 
H-negative risk:  675 691 1060 1176 425 388 97 111 118 143 52 64 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 76 25 

clinical_engagement 
diagnosis 
demography 
73 new agents 
205 
disease_progression 
H-positive risk:  689 668 110 1172 396 99 1057 427 146 63 120 53 
H-negative risk:  668 689 1057 1172 427 396 99 110 120 146 53 63 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 76 24 

clinical_engagement 
diagnosis 
demography 
85 new agents 
206 
disease_progression 
H-positive risk:  682 667 111 1155 412 101 1049 442 140 66 123 52 
H-negative risk:  667 682 1049 1155 442 412 101 111 123 140 52 66 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 74 24 

clinical_engagement 
diagnosis 
demography 
91 new agents 
207 
disease_progression 
H-positive risk:  690 664 117 1145 413 102 1039 449 135 68 126 52 
H-negative risk:  664 690 1039 1145 449 413 102 117 126 135 52 68 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 76 22 

clinical_engagement 
diagnosis 
demography 
77 new agents 
208 
disease_progression 
H-positive risk:  697 660 115 1142 419 105 1040 439 132 68 127 56 
H-negative risk:  660 697 1040 1142 439 419 105 115 127 132 56 68 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 73 22 

clinical_engagement 
diagnosis 
demography 
72 new agents 
209 
disease_progression 
H-positive risk:  700 647 116 1147 422 104 1039 437 133 67 133 55 
H-negative risk:  647 700 1039 1147 437 422 104 116 133 133 55 67 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 73 21 

clinical_engagement 
diagnosis 
demography 
71 new agents 
210 
disease_progression 
H-positive risk:  704 646 115 1147 422 103 1034 431 136 70 136 56 
H-negative risk:  646 704 1034 1147 431 422 103 115 136 136 56 70 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 75 21 

clinical_engagement 
diagnosis 
demography 
88 new agents 
211 
disease_progression 
H-positive risk:  711 647 118 1138 426 101 1029 431 135 72 139 53 
H-negative risk:  647 711 1029 1138 431 426 101 118 139 135 53 72 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 76 22 

clinical_engagement 
diagnosis 
demography 
68 new agents 
212 
disease_progression 
H-positive risk:  709 654 118 1137 422 100 1027 434 136 70 138 55 
H-negative risk:  654 709 1027 1137 434 422 100 118 138 136 55 70 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 76 22 

clinical_engagement 
diagnosis 
demography 
76 new agents 
213 
disease_progression 
H-positive risk:  704 652 120 1131 427 99 1034 430 136 71 142 54 
H-negative risk:  652 704 1034 1131 430 427 99 120 142 136 54 71 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 76 22 

clinical_engagement 
diagnosis 
demography 
86 new agents 
214 
disease_progression 
H-positive risk:  703 653 120 1127 420 97 1036 430 139 72 145 58 
H-negative risk:  653 703 1036 1127 430 420 97 120 145 139 58 72 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 77 22 

clinical_engagement 
diagnosis 
demography 
82 new agents 
215 
disease_progression 
H-positive risk:  703 644 121 1141 416 94 1046 420 138 73 145 59 
H-negative risk:  644 703 1046 1141 420 416 94 121 145 138 59 73 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 74 23 

clinical_engagement 
diagnosis 
demography 
76 new agents 
216 
disease_progression 
H-positive risk:  696 643 121 1153 417 94 1051 415 140 73 144 53 
H-negative risk:  643 696 1051 1153 415 417 94 121 144 140 53 73 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 73 23 

clinical_engagement 
diagnosis 
demography 
82 new agents 
217 
disease_progression 
H-positive risk:  695 643 121 1144 428 94 1045 421 136 75 144 54 
H-negative risk:  643 695 1045 1144 421 428 94 121 144 136 54 75 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 74 22 

clinical_engagement 
diagnosis 
demography 
77 new agents 
218 
disease_progression 
H-positive risk:  692 642 118 1153 424 97 1047 419 134 73 147 54 
H-negative risk:  642 692 1047 1153 419 424 97 118 147 134 54 73 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 74 22 

clinical_engagement 
diagnosis 
demography 
78 new agents 
219 
disease_progression 
H-positive risk:  685 639 117 1152 426 98 1053 420 134 72 151 53 
H-negative risk:  639 685 1053 1152 420 426 98 117 151 134 53 72 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 75 23 

clinical_engagement 
diagnosis 
demography 
98 new agents 
220 
disease_progression 
H-positive risk:  683 643 118 1157 420 98 1044 425 133 72 154 53 
H-negative risk:  643 683 1044 1157 425 420 98 118 154 133 53 72 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 74 24 

clinical_engagement 
diagnosis 
demography 
71 new agents 
221 
disease_progression 
H-positive risk:  684 652 118 1136 426 100 1048 423 131 71 155 56 
H-negative risk:  652 684 1048 1136 423 426 100 118 155 131 56 71 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 73 27 

clinical_engagement 
diagnosis 
demography 
64 new agents 
222 
disease_progression 
H-positive risk:  682 653 119 1128 434 98 1047 427 129 72 156 55 
H-negative risk:  653 682 1047 1128 427 434 98 119 156 129 55 72 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 75 26 

clinical_engagement 
diagnosis 
demography 
89 new agents 
223 
disease_progression 
H-positive risk:  682 656 116 1120 443 98 1047 428 127 70 160 53 
H-negative risk:  656 682 1047 1120 428 443 98 116 160 127 53 70 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 75 24 

clinical_engagement 
diagnosis 
demography 
82 new agents 
224 
disease_progression 
H-positive risk:  676 658 115 1118 445 101 1052 422 129 71 161 52 
H-negative risk:  658 676 1052 1118 422 445 101 115 161 129 52 71 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 73 23 

clinical_engagement 
diagnosis 
demography 
83 new agents 
225 
disease_progression 
H-positive risk:  673 659 117 1125 438 102 1054 424 128 71 158 51 
H-negative risk:  659 673 1054 1125 424 438 102 117 158 128 51 71 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 74 25 

clinical_engagement 
diagnosis 
demography 
77 new agents 
226 
disease_progression 
H-positive risk:  680 661 118 1125 441 101 1048 420 125 74 155 52 
H-negative risk:  661 680 1048 1125 420 441 101 118 155 125 52 74 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 75 25 

clinical_engagement 
diagnosis 
demography 
87 new agents 
227 
disease_progression 
H-positive risk:  675 665 117 1131 437 100 1051 414 125 75 157 53 
H-negative risk:  665 675 1051 1131 414 437 100 117 157 125 53 75 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 75 24 

clinical_engagement 
diagnosis 
demography 
69 new agents 
228 
disease_progression 
H-positive risk:  669 665 119 1128 439 102 1048 417 130 74 156 53 
H-negative risk:  665 669 1048 1128 417 439 102 119 156 130 53 74 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 75 24 

clinical_engagement 
diagnosis 
demography 
73 new agents 
229 
disease_progression 
H-positive risk:  674 664 119 1118 454 101 1036 427 127 72 157 51 
H-negative risk:  664 674 1036 1118 427 454 101 119 157 127 51 72 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 78 25 

clinical_engagement 
diagnosis 
demography 
103 new agents 
230 
disease_progression 
H-positive risk:  687 664 121 1122 447 105 1033 414 129 70 158 50 
H-negative risk:  664 687 1033 1122 414 447 105 121 158 129 50 70 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 78 24 

clinical_engagement 
diagnosis 
demography 
72 new agents 
231 
disease_progression 
H-positive risk:  686 667 122 1120 436 103 1037 415 132 69 162 51 
H-negative risk:  667 686 1037 1120 415 436 103 122 162 132 51 69 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 81 23 

clinical_engagement 
diagnosis 
demography 
64 new agents 
232 
disease_progression 
H-positive risk:  687 665 120 1108 441 103 1045 417 130 70 161 53 
H-negative risk:  665 687 1045 1108 417 441 103 120 161 130 53 70 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 83 23 

clinical_engagement 
diagnosis 
demography 
78 new agents 
233 
disease_progression 
H-positive risk:  690 661 119 1099 444 103 1045 421 131 68 160 59 
H-negative risk:  661 690 1045 1099 421 444 103 119 160 131 59 68 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 82 24 

clinical_engagement 
diagnosis 
demography 
69 new agents 
234 
disease_progression 
H-positive risk:  694 664 119 1101 439 104 1046 412 130 70 160 61 
H-negative risk:  664 694 1046 1101 412 439 104 119 160 130 61 70 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 80 24 

clinical_engagement 
diagnosis 
demography 
78 new agents 
235 
disease_progression 
H-positive risk:  691 668 120 1097 438 106 1048 408 132 70 160 62 
H-negative risk:  668 691 1048 1097 408 438 106 120 160 132 62 70 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 84 25 

clinical_engagement 
diagnosis 
demography 
79 new agents 
236 
disease_progression 
H-positive risk:  693 668 121 1099 436 106 1049 406 134 64 161 63 
H-negative risk:  668 693 1049 1099 406 436 106 121 161 134 63 64 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 83 25 

clinical_engagement 
diagnosis 
demography 
82 new agents 
237 
disease_progression 
H-positive risk:  688 673 124 1106 431 106 1046 411 133 61 159 62 
H-negative risk:  673 688 1046 1106 411 431 106 124 159 133 62 61 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 84 24 

clinical_engagement 
diagnosis 
demography 
96 new agents 
238 
disease_progression 
H-positive risk:  691 671 125 1114 429 105 1036 414 134 62 157 62 
H-negative risk:  671 691 1036 1114 414 429 105 125 157 134 62 62 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 80 25 

clinical_engagement 
diagnosis 
demography 
75 new agents 
239 
disease_progression 
H-positive risk:  691 667 121 1112 431 108 1044 411 134 63 156 62 
H-negative risk:  667 691 1044 1112 411 431 108 121 156 134 62 63 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 83 23 

clinical_engagement 
diagnosis 
demography 
64 new agents 
240 
disease_progression 
H-positive risk:  685 666 122 1116 430 108 1044 414 132 64 159 60 
H-negative risk:  666 685 1044 1116 414 430 108 122 159 132 60 64 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 82 22 

clinical_engagement 
diagnosis 
demography 
58 new agents 
241 
disease_progression 
H-positive risk:  687 664 121 1105 442 108 1029 430 130 64 160 60 
H-negative risk:  664 687 1029 1105 430 442 108 121 160 130 60 64 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 86 22 

clinical_engagement 
diagnosis 
demography 
71 new agents 
242 
disease_progression 
H-positive risk:  692 671 119 1098 440 104 1029 436 132 63 158 58 
H-negative risk:  671 692 1029 1098 436 440 104 119 158 132 58 63 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 83 22 

clinical_engagement 
diagnosis 
demography 
65 new agents 
243 
disease_progression 
H-positive risk:  693 670 122 1092 439 103 1036 433 133 65 155 59 
H-negative risk:  670 693 1036 1092 433 439 103 122 155 133 59 65 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 84 22 

clinical_engagement 
diagnosis 
demography 
75 new agents 
244 
disease_progression 
H-positive risk:  692 676 120 1089 439 102 1032 437 137 65 151 60 
H-negative risk:  676 692 1032 1089 437 439 102 120 151 137 60 65 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 81 23 

clinical_engagement 
diagnosis 
demography 
81 new agents 
245 
disease_progression 
H-positive risk:  698 683 120 1080 435 102 1032 434 141 63 153 59 
H-negative risk:  683 698 1032 1080 434 435 102 120 153 141 59 63 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 84 22 

clinical_engagement 
diagnosis 
demography 
75 new agents 
246 
disease_progression 
H-positive risk:  695 686 121 1087 441 102 1029 426 139 66 150 58 
H-negative risk:  686 695 1029 1087 426 441 102 121 150 139 58 66 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 84 21 

clinical_engagement 
diagnosis 
demography 
76 new agents 
247 
disease_progression 
H-positive risk:  699 676 120 1083 456 101 1028 425 140 62 153 57 
H-negative risk:  676 699 1028 1083 425 456 101 120 153 140 57 62 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 84 22 

clinical_engagement 
diagnosis 
demography 
73 new agents 
248 
disease_progression 
H-positive risk:  697 669 120 1088 455 102 1032 422 142 60 156 57 
H-negative risk:  669 697 1032 1088 422 455 102 120 156 142 57 60 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 83 22 

clinical_engagement 
diagnosis 
demography 
74 new agents 
249 
disease_progression 
H-positive risk:  688 665 117 1085 461 102 1049 418 140 59 159 57 
H-negative risk:  665 688 1049 1085 418 461 102 117 159 140 57 59 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 84 21 

clinical_engagement 
diagnosis 
demography 
68 new agents 
250 
disease_progression 
H-positive risk:  697 654 118 1080 468 104 1053 413 141 54 160 58 
H-negative risk:  654 697 1053 1080 413 468 104 118 160 141 58 54 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 87 21 

clinical_engagement 
diagnosis 
demography 
73 new agents 
251 
disease_progression 
H-positive risk:  702 652 119 1081 461 104 1057 411 144 50 162 57 
H-negative risk:  652 702 1057 1081 411 461 104 119 162 144 57 50 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 86 23 

clinical_engagement 
diagnosis 
demography 
64 new agents 
252 
disease_progression 
H-positive risk:  700 648 119 1076 461 106 1062 418 143 50 160 57 
H-negative risk:  648 700 1062 1076 418 461 106 119 160 143 57 50 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 86 25 

clinical_engagement 
diagnosis 
demography 
73 new agents 
253 
disease_progression 
H-positive risk:  709 645 116 1086 461 103 1053 420 143 49 160 55 
H-negative risk:  645 709 1053 1086 420 461 103 116 160 143 55 49 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 85 25 

clinical_engagement 
diagnosis 
demography 
86 new agents 
254 
disease_progression 
H-positive risk:  718 649 115 1086 456 102 1045 420 146 45 161 57 
H-negative risk:  649 718 1045 1086 420 456 102 115 161 146 57 45 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 82 26 

clinical_engagement 
diagnosis 
demography 
81 new agents 
255 
disease_progression 
H-positive risk:  725 646 117 1090 454 104 1039 415 146 46 160 58 
H-negative risk:  646 725 1039 1090 415 454 104 117 160 146 58 46 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 83 26 

clinical_engagement 
diagnosis 
demography 
76 new agents 
256 
disease_progression 
H-positive risk:  730 648 115 1080 451 107 1042 411 148 46 161 61 
H-negative risk:  648 730 1042 1080 411 451 107 115 161 148 61 46 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 86 26 

clinical_engagement 
diagnosis 
demography 
68 new agents 
257 
disease_progression 
H-positive risk:  734 649 109 1079 448 106 1042 413 145 48 166 61 
H-negative risk:  649 734 1042 1079 413 448 106 109 166 145 61 48 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 87 25 

clinical_engagement 
diagnosis 
demography 
76 new agents 
258 
disease_progression 
H-positive risk:  732 646 108 1078 448 104 1051 414 147 46 167 59 
H-negative risk:  646 732 1051 1078 414 448 104 108 167 147 59 46 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 86 26 

clinical_engagement 
diagnosis 
demography 
71 new agents 
259 
disease_progression 
H-positive risk:  731 646 107 1075 444 104 1063 413 142 46 168 61 
H-negative risk:  646 731 1063 1075 413 444 104 107 168 142 61 46 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 87 26 

clinical_engagement 
diagnosis 
demography 
79 new agents 
260 
disease_progression 
H-positive risk:  732 653 107 1072 441 104 1049 424 139 50 168 61 
H-negative risk:  653 732 1049 1072 424 441 104 107 168 139 61 50 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 88 24 

clinical_engagement 
diagnosis 
demography 
74 new agents 
261 
disease_progression 
H-positive risk:  738 658 107 1077 439 106 1036 422 140 49 169 59 
H-negative risk:  658 738 1036 1077 422 439 106 107 169 140 59 49 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 88 26 

clinical_engagement 
diagnosis 
demography 
85 new agents 
262 
disease_progression 
H-positive risk:  732 656 107 1078 443 105 1039 416 145 45 173 61 
H-negative risk:  656 732 1039 1078 416 443 105 107 173 145 61 45 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 87 25 

clinical_engagement 
diagnosis 
demography 
88 new agents 
263 
disease_progression 
H-positive risk:  735 652 107 1074 445 105 1044 407 149 45 173 64 
H-negative risk:  652 735 1044 1074 407 445 105 107 173 149 64 45 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 87 23 

clinical_engagement 
diagnosis 
demography 
83 new agents 
264 
disease_progression 
H-positive risk:  730 659 104 1078 441 104 1045 411 148 44 170 66 
H-negative risk:  659 730 1045 1078 411 441 104 104 170 148 66 44 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 90 23 

clinical_engagement 
diagnosis 
demography 
95 new agents 
265 
disease_progression 
H-positive risk:  728 661 103 1078 438 104 1049 409 152 43 169 66 
H-negative risk:  661 728 1049 1078 409 438 104 103 169 152 66 43 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 93 24 

clinical_engagement 
diagnosis 
demography 
76 new agents 
266 
disease_progression 
H-positive risk:  719 664 105 1086 434 104 1060 398 155 44 168 63 
H-negative risk:  664 719 1060 1086 398 434 104 105 168 155 63 44 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 94 24 

clinical_engagement 
diagnosis 
demography 
65 new agents 
267 
disease_progression 
H-positive risk:  716 668 106 1085 441 101 1051 405 154 45 166 62 
H-negative risk:  668 716 1051 1085 405 441 101 106 166 154 62 45 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 93 23 

clinical_engagement 
diagnosis 
demography 
71 new agents 
268 
disease_progression 
H-positive risk:  712 672 108 1079 440 100 1062 403 156 44 165 59 
H-negative risk:  672 712 1062 1079 403 440 100 108 165 156 59 44 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 93 22 

clinical_engagement 
diagnosis 
demography 
73 new agents 
269 
disease_progression 
H-positive risk:  706 669 107 1080 440 101 1061 411 156 46 165 58 
H-negative risk:  669 706 1061 1080 411 440 101 107 165 156 58 46 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 89 24 

clinical_engagement 
diagnosis 
demography 
98 new agents 
270 
disease_progression 
H-positive risk:  706 672 103 1085 431 103 1072 404 155 47 165 57 
H-negative risk:  672 706 1072 1085 404 431 103 103 165 155 57 47 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 90 23 

clinical_engagement 
diagnosis 
demography 
77 new agents 
271 
disease_progression 
H-positive risk:  700 674 104 1084 428 103 1076 406 157 46 167 55 
H-negative risk:  674 700 1076 1084 406 428 103 104 167 157 55 46 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 92 21 

clinical_engagement 
diagnosis 
demography 
79 new agents 
272 
disease_progression 
H-positive risk:  700 674 102 1083 428 99 1081 406 159 45 166 57 
H-negative risk:  674 700 1081 1083 406 428 99 102 166 159 57 45 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 90 23 

clinical_engagement 
diagnosis 
demography 
78 new agents 
273 
disease_progression 
H-positive risk:  704 676 99 1082 419 101 1085 404 158 46 169 57 
H-negative risk:  676 704 1085 1082 404 419 101 99 169 158 57 46 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 90 23 

clinical_engagement 
diagnosis 
demography 
84 new agents 
274 
disease_progression 
H-positive risk:  713 668 100 1072 430 100 1089 402 156 46 168 56 
H-negative risk:  668 713 1089 1072 402 430 100 100 168 156 56 46 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 88 23 

clinical_engagement 
diagnosis 
demography 
66 new agents 
275 
disease_progression 
H-positive risk:  708 670 102 1079 429 100 1087 402 151 47 167 58 
H-negative risk:  670 708 1087 1079 402 429 100 102 167 151 58 47 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 89 24 

clinical_engagement 
diagnosis 
demography 
59 new agents 
276 
disease_progression 
H-positive risk:  705 670 100 1077 435 96 1086 409 154 46 164 58 
H-negative risk:  670 705 1086 1077 409 435 96 100 164 154 58 46 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 87 26 

clinical_engagement 
diagnosis 
demography 
62 new agents 
277 
disease_progression 
H-positive risk:  710 677 100 1072 430 99 1076 412 154 45 166 59 
H-negative risk:  677 710 1076 1072 412 430 99 100 166 154 59 45 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 83 26 

clinical_engagement 
diagnosis 
demography 
75 new agents 
278 
disease_progression 
H-positive risk:  704 681 100 1058 440 99 1083 412 151 50 162 60 
H-negative risk:  681 704 1083 1058 412 440 99 100 162 151 60 50 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 82 27 

clinical_engagement 
diagnosis 
demography 
74 new agents 
279 
disease_progression 
H-positive risk:  703 680 100 1060 437 97 1082 415 153 48 162 63 
H-negative risk:  680 703 1082 1060 415 437 97 100 162 153 63 48 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 82 25 

clinical_engagement 
diagnosis 
demography 
75 new agents 
280 
disease_progression 
H-positive risk:  706 682 100 1062 433 97 1082 416 152 45 160 65 
H-negative risk:  682 706 1082 1062 416 433 97 100 160 152 65 45 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 81 27 

clinical_engagement 
diagnosis 
demography 
62 new agents 
281 
disease_progression 
H-positive risk:  710 679 103 1050 441 98 1082 418 150 47 157 65 
H-negative risk:  679 710 1082 1050 418 441 98 103 157 150 65 47 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 79 27 

clinical_engagement 
diagnosis 
demography 
73 new agents 
282 
disease_progression 
H-positive risk:  715 680 105 1052 435 96 1092 410 150 46 155 64 
H-negative risk:  680 715 1092 1052 410 435 96 105 155 150 64 46 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 76 28 

clinical_engagement 
diagnosis 
demography 
76 new agents 
283 
disease_progression 
H-positive risk:  710 683 101 1046 432 95 1094 420 150 48 158 63 
H-negative risk:  683 710 1094 1046 420 432 95 101 158 150 63 48 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 79 26 

clinical_engagement 
diagnosis 
demography 
69 new agents 
284 
disease_progression 
H-positive risk:  710 681 102 1042 433 93 1103 420 150 48 156 62 
H-negative risk:  681 710 1103 1042 420 433 93 102 156 150 62 48 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 79 26 

clinical_engagement 
diagnosis 
demography 
83 new agents 
285 
disease_progression 
H-positive risk:  713 683 99 1047 428 94 1097 424 147 50 159 59 
H-negative risk:  683 713 1097 1047 424 428 94 99 159 147 59 50 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 79 26 

clinical_engagement 
diagnosis 
demography 
87 new agents 
286 
disease_progression 
H-positive risk:  708 687 100 1039 425 92 1113 415 152 47 159 63 
H-negative risk:  687 708 1113 1039 415 425 92 100 159 152 63 47 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 79 25 

clinical_engagement 
diagnosis 
demography 
75 new agents 
287 
disease_progression 
H-positive risk:  707 690 99 1030 417 90 1113 424 155 48 165 62 
H-negative risk:  690 707 1113 1030 424 417 90 99 165 155 62 48 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 80 26 

clinical_engagement 
diagnosis 
demography 
68 new agents 
288 
disease_progression 
H-positive risk:  709 690 101 1022 426 91 1117 416 154 49 166 59 
H-negative risk:  690 709 1117 1022 416 426 91 101 166 154 59 49 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 81 26 

clinical_engagement 
diagnosis 
demography 
69 new agents 
289 
disease_progression 
H-positive risk:  707 686 100 1028 424 92 1113 416 158 48 168 60 
H-negative risk:  686 707 1113 1028 416 424 92 100 168 158 60 48 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 82 26 

clinical_engagement 
diagnosis 
demography 
85 new agents 
290 
disease_progression 
H-positive risk:  702 687 98 1022 424 91 1130 403 163 50 169 61 
H-negative risk:  687 702 1130 1022 403 424 91 98 169 163 61 50 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 81 26 

clinical_engagement 
diagnosis 
demography 
72 new agents 
291 
disease_progression 
H-positive risk:  705 691 94 1011 424 95 1134 402 158 52 174 60 
H-negative risk:  691 705 1134 1011 402 424 95 94 174 158 60 52 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 82 26 

clinical_engagement 
diagnosis 
demography 
62 new agents 
292 
disease_progression 
H-positive risk:  701 697 92 1011 428 93 1133 398 159 52 175 61 
H-negative risk:  697 701 1133 1011 398 428 93 92 175 159 61 52 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 80 26 

clinical_engagement 
diagnosis 
demography 
68 new agents 
293 
disease_progression 
H-positive risk:  699 697 90 1017 425 91 1130 403 163 52 168 65 
H-negative risk:  697 699 1130 1017 403 425 91 90 168 163 65 52 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 81 26 

clinical_engagement 
diagnosis 
demography 
70 new agents 
294 
disease_progression 
H-positive risk:  702 689 87 1021 424 91 1130 406 165 50 167 68 
H-negative risk:  689 702 1130 1021 406 424 91 87 167 165 68 50 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 79 26 

clinical_engagement 
diagnosis 
demography 
80 new agents 
295 
disease_progression 
H-positive risk:  704 691 86 1017 423 92 1133 402 166 50 168 68 
H-negative risk:  691 704 1133 1017 402 423 92 86 168 166 68 50 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 80 26 

clinical_engagement 
diagnosis 
demography 
84 new agents 
296 
disease_progression 
H-positive risk:  703 691 85 1023 414 93 1136 402 166 49 172 66 
H-negative risk:  691 703 1136 1023 402 414 93 85 172 166 66 49 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 79 26 

clinical_engagement 
diagnosis 
demography 
65 new agents 
297 
disease_progression 
H-positive risk:  699 685 86 1029 415 94 1149 390 167 47 168 71 
H-negative risk:  685 699 1149 1029 390 415 94 86 168 167 71 47 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 78 27 

clinical_engagement 
diagnosis 
demography 
61 new agents 
298 
disease_progression 
H-positive risk:  692 687 87 1036 408 97 1150 393 166 45 168 71 
H-negative risk:  687 692 1150 1036 393 408 97 87 168 166 71 45 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 78 27 

clinical_engagement 
diagnosis 
demography 
87 new agents 
299 
disease_progression 
H-positive risk:  695 688 85 1034 416 97 1146 389 170 44 164 72 
H-negative risk:  688 695 1146 1034 389 416 97 85 164 170 72 44 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 78 28 

clinical_engagement 
diagnosis 
demography 
74 new agents 
300 
disease_progression 
H-positive risk:  703 686 85 1044 412 98 1141 385 170 41 165 70 
H-negative risk:  686 703 1141 1044 385 412 98 85 165 170 70 41 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 77 28 

clinical_engagement 
diagnosis 
demography 
77 new agents 
301 
disease_progression 
H-positive risk:  700 688 88 1053 413 97 1136 377 169 44 164 71 
H-negative risk:  688 700 1136 1053 377 413 97 88 164 169 71 44 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 76 27 

clinical_engagement 
diagnosis 
demography 
80 new agents 
302 
disease_progression 
H-positive risk:  697 688 88 1049 413 96 1132 385 173 43 164 72 
H-negative risk:  688 697 1132 1049 385 413 96 88 164 173 72 43 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 76 28 

clinical_engagement 
diagnosis 
demography 
73 new agents 
303 
disease_progression 
H-positive risk:  696 697 84 1050 411 97 1117 394 173 45 164 72 
H-negative risk:  697 696 1117 1050 394 411 97 84 164 173 72 45 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 77 27 

clinical_engagement 
diagnosis 
demography 
79 new agents 
304 
disease_progression 
H-positive risk:  698 694 85 1053 408 100 1111 398 172 47 164 70 
H-negative risk:  694 698 1111 1053 398 408 100 85 164 172 70 47 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 76 27 

clinical_engagement 
diagnosis 
demography 
73 new agents 
305 
disease_progression 
H-positive risk:  692 698 85 1048 406 102 1115 406 173 48 160 67 
H-negative risk:  698 692 1115 1048 406 406 102 85 160 173 67 48 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 77 25 

clinical_engagement 
diagnosis 
demography 
85 new agents 
306 
disease_progression 
H-positive risk:  701 694 85 1055 404 104 1113 394 173 48 161 68 
H-negative risk:  694 701 1113 1055 394 404 104 85 161 173 68 48 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 82 25 

clinical_engagement 
diagnosis 
demography 
90 new agents 
307 
disease_progression 
H-positive risk:  695 701 86 1039 407 105 1115 402 172 47 162 69 
H-negative risk:  701 695 1115 1039 402 407 105 86 162 172 69 47 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 81 24 

clinical_engagement 
diagnosis 
demography 
80 new agents 
308 
disease_progression 
H-positive risk:  691 708 85 1028 405 108 1120 402 172 50 160 71 
H-negative risk:  708 691 1120 1028 402 405 108 85 160 172 71 50 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 83 25 

clinical_engagement 
diagnosis 
demography 
60 new agents 
309 
disease_progression 
H-positive risk:  685 712 81 1022 410 108 1126 404 170 51 162 69 
H-negative risk:  712 685 1126 1022 404 410 108 81 162 170 69 51 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 84 26 

clinical_engagement 
diagnosis 
demography 
81 new agents 
310 
disease_progression 
H-positive risk:  686 709 82 1039 402 105 1126 397 170 54 163 67 
H-negative risk:  709 686 1126 1039 397 402 105 82 163 170 67 54 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 83 23 

clinical_engagement 
diagnosis 
demography 
76 new agents 
311 
disease_progression 
H-positive risk:  684 705 82 1036 397 103 1134 408 168 57 161 65 
H-negative risk:  705 684 1134 1036 408 397 103 82 161 168 65 57 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 82 23 

clinical_engagement 
diagnosis 
demography 
84 new agents 
312 
disease_progression 
H-positive risk:  686 701 83 1032 405 103 1129 409 173 55 158 66 
H-negative risk:  701 686 1129 1032 409 405 103 83 158 173 66 55 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 81 23 

clinical_engagement 
diagnosis 
demography 
74 new agents 
313 
disease_progression 
H-positive risk:  687 703 87 1029 406 105 1130 408 167 57 157 64 
H-negative risk:  703 687 1130 1029 408 406 105 87 157 167 64 57 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 83 23 

clinical_engagement 
diagnosis 
demography 
86 new agents 
314 
disease_progression 
H-positive risk:  681 715 86 1023 414 103 1119 413 170 56 158 62 
H-negative risk:  715 681 1119 1023 413 414 103 86 158 170 62 56 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 83 23 

clinical_engagement 
diagnosis 
demography 
67 new agents 
315 
disease_progression 
H-positive risk:  673 718 86 1025 413 103 1110 418 169 57 163 65 
H-negative risk:  718 673 1110 1025 418 413 103 86 163 169 65 57 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 83 23 

clinical_engagement 
diagnosis 
demography 
69 new agents 
316 
disease_progression 
H-positive risk:  671 715 86 1034 412 104 1106 416 171 56 162 67 
H-negative risk:  715 671 1106 1034 416 412 104 86 162 171 67 56 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 82 23 

clinical_engagement 
diagnosis 
demography 
49 new agents 
317 
disease_progression 
H-positive risk:  667 707 85 1047 420 107 1098 415 168 57 162 67 
H-negative risk:  707 667 1098 1047 415 420 107 85 162 168 67 57 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 83 23 

clinical_engagement 
diagnosis 
demography 
78 new agents 
318 
disease_progression 
H-positive risk:  659 710 85 1046 418 107 1110 406 171 57 164 67 
H-negative risk:  710 659 1110 1046 406 418 107 85 164 171 67 57 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 83 23 

clinical_engagement 
diagnosis 
demography 
64 new agents 
319 
disease_progression 
H-positive risk:  655 710 87 1045 422 105 1111 406 170 57 164 68 
H-negative risk:  710 655 1111 1045 406 422 105 87 164 170 68 57 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 84 23 

clinical_engagement 
diagnosis 
demography 
86 new agents 
320 
disease_progression 
H-positive risk:  661 714 86 1033 424 104 1116 410 168 56 163 65 
H-negative risk:  714 661 1116 1033 410 424 104 86 163 168 65 56 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 78 23 

clinical_engagement 
diagnosis 
demography 
74 new agents 
321 
disease_progression 
H-positive risk:  655 720 87 1032 428 108 1112 403 168 60 160 67 
H-negative risk:  720 655 1112 1032 403 428 108 87 160 168 67 60 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 80 22 

clinical_engagement 
diagnosis 
demography 
66 new agents 
322 
disease_progression 
H-positive risk:  654 720 82 1034 429 108 1117 401 167 62 160 66 
H-negative risk:  720 654 1117 1034 401 429 108 82 160 167 66 62 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 79 22 

clinical_engagement 
diagnosis 
demography 
73 new agents 
323 
disease_progression 
H-positive risk:  656 721 81 1035 423 106 1117 404 169 64 160 64 
H-negative risk:  721 656 1117 1035 404 423 106 81 160 169 64 64 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 81 21 

clinical_engagement 
diagnosis 
demography 
79 new agents 
324 
disease_progression 
H-positive risk:  657 713 78 1032 430 105 1118 406 172 63 164 62 
H-negative risk:  713 657 1118 1032 406 430 105 78 164 172 62 63 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 81 21 

clinical_engagement 
diagnosis 
demography 
70 new agents 
325 
disease_progression 
H-positive risk:  658 712 80 1036 426 105 1123 406 171 64 161 58 
H-negative risk:  712 658 1123 1036 406 426 105 80 161 171 58 64 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 82 22 

clinical_engagement 
diagnosis 
demography 
64 new agents 
326 
disease_progression 
H-positive risk:  657 711 80 1040 432 104 1123 404 167 65 159 58 
H-negative risk:  711 657 1123 1040 404 432 104 80 159 167 58 65 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 83 21 

clinical_engagement 
diagnosis 
demography 
72 new agents 
327 
disease_progression 
H-positive risk:  654 709 83 1036 433 107 1127 406 165 64 157 59 
H-negative risk:  709 654 1127 1036 406 433 107 83 157 165 59 64 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 84 20 

clinical_engagement 
diagnosis 
demography 
63 new agents 
328 
disease_progression 
H-positive risk:  647 708 83 1038 427 105 1133 411 167 63 158 60 
H-negative risk:  708 647 1133 1038 411 427 105 83 158 167 60 63 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 87 20 

clinical_engagement 
diagnosis 
demography 
69 new agents 
329 
disease_progression 
H-positive risk:  650 704 87 1034 429 101 1115 423 171 65 160 61 
H-negative risk:  704 650 1115 1034 423 429 101 87 160 171 61 65 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 87 20 

clinical_engagement 
diagnosis 
demography 
86 new agents 
330 
disease_progression 
H-positive risk:  649 703 88 1034 428 100 1118 418 175 62 162 63 
H-negative risk:  703 649 1118 1034 418 428 100 88 162 175 63 62 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 89 20 

clinical_engagement 
diagnosis 
demography 
79 new agents 
331 
disease_progression 
H-positive risk:  651 710 87 1031 423 100 1121 420 173 63 160 61 
H-negative risk:  710 651 1121 1031 420 423 100 87 160 173 61 63 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 92 20 

clinical_engagement 
diagnosis 
demography 
91 new agents 
332 
disease_progression 
H-positive risk:  645 713 90 1026 410 101 1142 419 172 65 156 61 
H-negative risk:  713 645 1142 1026 419 410 101 90 156 172 61 65 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 90 20 

clinical_engagement 
diagnosis 
demography 
72 new agents 
333 
disease_progression 
H-positive risk:  642 712 94 1030 407 99 1136 421 172 65 161 61 
H-negative risk:  712 642 1136 1030 421 407 99 94 161 172 61 65 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 89 20 

clinical_engagement 
diagnosis 
demography 
85 new agents 
334 
disease_progression 
H-positive risk:  642 713 97 1030 413 98 1130 420 172 62 162 61 
H-negative risk:  713 642 1130 1030 420 413 98 97 162 172 61 62 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 85 20 

clinical_engagement 
diagnosis 
demography 
72 new agents 
335 
disease_progression 
H-positive risk:  642 712 98 1030 415 97 1132 417 172 61 162 62 
H-negative risk:  712 642 1132 1030 417 415 97 98 162 172 62 61 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 88 20 

clinical_engagement 
diagnosis 
demography 
76 new agents 
336 
disease_progression 
H-positive risk:  640 713 97 1031 406 97 1137 421 174 60 158 66 
H-negative risk:  713 640 1137 1031 421 406 97 97 158 174 66 60 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 87 20 

clinical_engagement 
diagnosis 
demography 
80 new agents 
337 
disease_progression 
H-positive risk:  645 713 96 1031 414 94 1124 421 176 63 157 66 
H-negative risk:  713 645 1124 1031 421 414 94 96 157 176 66 63 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 86 21 

clinical_engagement 
diagnosis 
demography 
72 new agents 
338 
disease_progression 
H-positive risk:  643 711 99 1035 418 94 1121 419 173 64 155 68 
H-negative risk:  711 643 1121 1035 419 418 94 99 155 173 68 64 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 87 22 

clinical_engagement 
diagnosis 
demography 
73 new agents 
339 
disease_progression 
H-positive risk:  638 711 100 1037 412 97 1123 425 170 64 158 65 
H-negative risk:  711 638 1123 1037 425 412 97 100 158 170 65 64 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 86 23 

clinical_engagement 
diagnosis 
demography 
73 new agents 
340 
disease_progression 
H-positive risk:  632 706 102 1047 412 99 1123 429 171 61 154 64 
H-negative risk:  706 632 1123 1047 429 412 99 102 154 171 64 61 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 86 24 

clinical_engagement 
diagnosis 
demography 
71 new agents 
341 
disease_progression 
H-positive risk:  634 705 105 1049 402 99 1130 430 167 62 151 66 
H-negative risk:  705 634 1130 1049 430 402 99 105 151 167 66 62 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 86 22 

clinical_engagement 
diagnosis 
demography 
72 new agents 
342 
disease_progression 
H-positive risk:  626 713 103 1050 402 99 1126 435 163 63 155 65 
H-negative risk:  713 626 1126 1050 435 402 99 103 155 163 65 63 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 85 22 

clinical_engagement 
diagnosis 
demography 
65 new agents 
343 
disease_progression 
H-positive risk:  617 722 105 1051 398 100 1129 430 161 65 157 65 
H-negative risk:  722 617 1129 1051 430 398 100 105 157 161 65 65 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 83 24 

clinical_engagement 
diagnosis 
demography 
79 new agents 
344 
disease_progression 
H-positive risk:  617 719 104 1067 387 97 1125 433 163 64 161 63 
H-negative risk:  719 617 1125 1067 433 387 97 104 161 163 63 64 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 81 25 

clinical_engagement 
diagnosis 
demography 
76 new agents 
345 
disease_progression 
H-positive risk:  617 720 103 1070 383 95 1130 435 164 61 160 62 
H-negative risk:  720 617 1130 1070 435 383 95 103 160 164 62 61 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 76 25 

clinical_engagement 
diagnosis 
demography 
74 new agents 
346 
disease_progression 
H-positive risk:  608 721 102 1067 389 94 1134 443 164 60 158 60 
H-negative risk:  721 608 1134 1067 443 389 94 102 158 164 60 60 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 75 24 

clinical_engagement 
diagnosis 
demography 
74 new agents 
347 
disease_progression 
H-positive risk:  609 711 99 1060 397 94 1134 446 166 59 162 63 
H-negative risk:  711 609 1134 1060 446 397 94 99 162 166 63 59 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 74 24 

clinical_engagement 
diagnosis 
demography 
84 new agents 
348 
disease_progression 
H-positive risk:  605 704 103 1061 400 96 1133 445 165 63 163 62 
H-negative risk:  704 605 1133 1061 445 400 96 103 163 165 62 63 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 76 24 

clinical_engagement 
diagnosis 
demography 
76 new agents 
349 
disease_progression 
H-positive risk:  604 704 99 1065 392 94 1136 445 167 67 165 62 
H-negative risk:  704 604 1136 1065 445 392 94 99 165 167 62 67 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 77 24 

clinical_engagement 
diagnosis 
demography 
66 new agents 
350 
disease_progression 
H-positive risk:  601 699 95 1069 391 96 1142 442 167 68 167 63 
H-negative risk:  699 601 1142 1069 442 391 96 95 167 167 63 68 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 76 24 

clinical_engagement 
diagnosis 
demography 
92 new agents 
351 
disease_progression 
H-positive risk:  607 698 93 1071 389 98 1131 449 167 67 167 63 
H-negative risk:  698 607 1131 1071 449 389 98 93 167 167 63 67 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 75 26 

clinical_engagement 
diagnosis 
demography 
91 new agents 
352 
disease_progression 
H-positive risk:  611 700 92 1073 393 96 1122 454 167 65 167 60 
H-negative risk:  700 611 1122 1073 454 393 96 92 167 167 60 65 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 75 25 

clinical_engagement 
diagnosis 
demography 
85 new agents 
353 
disease_progression 
H-positive risk:  604 702 97 1070 388 99 1129 449 170 64 166 62 
H-negative risk:  702 604 1129 1070 449 388 99 97 166 170 62 64 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 76 25 

clinical_engagement 
diagnosis 
demography 
83 new agents 
354 
disease_progression 
H-positive risk:  615 698 97 1075 384 98 1118 446 172 65 170 62 
H-negative risk:  698 615 1118 1075 446 384 98 97 170 172 62 65 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 75 25 

clinical_engagement 
diagnosis 
demography 
83 new agents 
355 
disease_progression 
H-positive risk:  624 688 97 1074 390 98 1116 442 173 64 171 63 
H-negative risk:  688 624 1116 1074 442 390 98 97 171 173 63 64 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 75 24 

clinical_engagement 
diagnosis 
demography 
68 new agents 
356 
disease_progression 
H-positive risk:  624 692 94 1074 393 98 1109 444 175 65 170 62 
H-negative risk:  692 624 1109 1074 444 393 98 94 170 175 62 65 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 75 23 

clinical_engagement 
diagnosis 
demography 
78 new agents 
357 
disease_progression 
H-positive risk:  635 688 95 1077 393 98 1093 448 176 69 165 63 
H-negative risk:  688 635 1093 1077 448 393 98 95 165 176 63 69 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 74 23 

clinical_engagement 
diagnosis 
demography 
79 new agents 
358 
disease_progression 
H-positive risk:  643 690 96 1077 399 98 1080 452 171 66 164 64 
H-negative risk:  690 643 1080 1077 452 399 98 96 164 171 64 66 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 75 22 

clinical_engagement 
diagnosis 
demography 
68 new agents 
359 
disease_progression 
H-positive risk:  645 692 94 1065 406 99 1083 458 165 64 165 64 
H-negative risk:  692 645 1083 1065 458 406 99 94 165 165 64 64 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 74 24 

clinical_engagement 
diagnosis 
demography 
87 new agents 
360 
disease_progression 
H-positive risk:  646 692 96 1058 405 99 1086 457 167 65 167 62 
H-negative risk:  692 646 1086 1058 457 405 99 96 167 167 62 65 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 74 24 

clinical_engagement 
diagnosis 
demography 
66 new agents 
Time difference of 19.62731 mins
This is task 11
date
